<html xmlns="http://www.w3.org/1999/xhtml" xml:lang="en" lang="en"><head><meta http-equiv="Content-Type" content="text/html; charset=utf-8">
        <!-- AppResources meta begin -->
        <script type="text/javascript">var ncbi_startTime = new Date();</script>
        <!-- AppResources meta end -->
        
        <!-- TemplateResources meta begin -->
        <meta name="paf_template" content="">

        <!-- TemplateResources meta end -->
        
        <!-- Logger begin -->
        <meta name="ncbi_db" content="pmc"><meta name="ncbi_pdid" content="article"><meta name="ncbi_acc" content=""><meta name="ncbi_domain" content="nihpa"><meta name="ncbi_report" content="record"><meta name="ncbi_type" content="fulltext"><meta name="ncbi_objectid" content=""><meta name="ncbi_pcid" content="/articles/PMC3676425/"><meta name="ncbi_app" content="pmc">
        <!-- Logger end -->
        
        <title>A germline JAK2 SNP is associated with predisposition to the development of JAK2V617F-positive myeloproliferative neoplasms</title>
        
        <!-- AppResources external_resources begin -->
        <link rel="stylesheet" href="/core/jig/1.14.8/css/jig.min.css"><script type="text/javascript" src="/core/jig/1.14.8/js/jig.min.js"></script>

        <!-- AppResources external_resources end -->
        
        <!-- Page meta begin -->
        <meta name="robots" content="INDEX,NOFOLLOW,NOARCHIVE"><link rel="canonical" href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3676425/"><link rel="schema.DC" href="http://purl.org/DC/elements/1.0/"><meta name="citation_journal_title" content="Nature genetics"><meta name="citation_title" content="A germline JAK2 SNP is associated with predisposition to the development of JAK2V617F-positive myeloproliferative neoplasms"><meta name="citation_authors" content="Outi Kilpivaara, Semanti Mukherjee, Alison M Schram, Martha Wadleigh, Ann Mullally, Benjamin L Ebert, Adam Bass, Sachie Marubayashi, Adriana Heguy, Guillermo Garcia-Manero, Hagop Kantarjian, Kenneth Offit, Richard M Stone, D Gary Gilliland, Robert J Klein, Ross L Levine"><meta name="citation_date" content="April 2009"><meta name="citation_issue" content="4"><meta name="citation_volume" content="41"><meta name="citation_firstpage" content="455"><meta name="citation_doi" content="10.1038/ng.342"><meta name="citation_abstract_html_url" content="/pmc/articles/PMC3676425/?report=abstract"><meta name="citation_pmid" content="19287384"><meta name="DC.Title" content="A germline JAK2 SNP is associated with predisposition to the development of JAK2V617F-positive myeloproliferative neoplasms"><meta name="DC.Type" content="Text"><meta name="DC.Publisher" content="NIH Public Access"><meta name="DC.Contributor" content="Outi Kilpivaara"><meta name="DC.Contributor" content="Semanti Mukherjee"><meta name="DC.Contributor" content="Alison M Schram"><meta name="DC.Contributor" content="Martha Wadleigh"><meta name="DC.Contributor" content="Ann Mullally"><meta name="DC.Contributor" content="Benjamin L Ebert"><meta name="DC.Contributor" content="Adam Bass"><meta name="DC.Contributor" content="Sachie Marubayashi"><meta name="DC.Contributor" content="Adriana Heguy"><meta name="DC.Contributor" content="Guillermo Garcia-Manero"><meta name="DC.Contributor" content="Hagop Kantarjian"><meta name="DC.Contributor" content="Kenneth Offit"><meta name="DC.Contributor" content="Richard M Stone"><meta name="DC.Contributor" content="D Gary Gilliland"><meta name="DC.Contributor" content="Robert J Klein"><meta name="DC.Contributor" content="Ross L Levine"><meta name="DC.Date" content="2009 Apr"><meta name="DC.Identifier" content="10.1038/ng.342"><meta name="DC.Language" content="en"><meta property="og:title" content="A germline JAK2 SNP is associated with predisposition to the development of JAK2V617F-positive myeloproliferative neoplasms"><meta property="og:type" content="article"><meta property="og:description" content="Polycythemia vera, essential thrombocythemia and primary myelofibrosis are myeloproliferative neoplasms (MPN) characterized by multilineage clonal hematopoiesis[–] . Given that the identical somatic activating mutation in the JAK2 tyrosine kinase ..."><meta property="og:url" content="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3676425/"><meta property="og:site_name" content="PubMed Central (PMC)"><meta property="og:image" content="https://www.ncbi.nlm.nih.gov/corehtml/pmc/pmcgifs/pmc-logo-share.png"><meta name="twitter:card" content="summary"><meta name="twitter:site" content="@ncbi"><meta name="ncbi_feature" content="associated_data"><link rel="stylesheet" href="/corehtml/pmc/css/3.14.1/pmc.min.css" type="text/css"><link rel="stylesheet" href="/corehtml/pmc/css/3.14.1/pmc_extras_prnt.min.css" type="text/css" media="print"><script type="text/javascript" src="/corehtml/pmc/js/common.min.js">//</script><script type="text/javascript" src="/corehtml/pmc/js/NcbiTagServer.min.js">//</script><meta name="citationexporter" content="backend:'https://api.ncbi.nlm.nih.gov/lit/ctxp/v1/pmc/'"><script type="text/javascript" src="https://www.ncbi.nlm.nih.gov/corehtml/pmc/ctxp/jquery.citationexporter.min.js">//</script><link rel="stylesheet" href="https://www.ncbi.nlm.nih.gov/corehtml/pmc/ctxp/citationexporter.css" type="text/css"><script type="text/javascript" src="/core/mathjax/2.6.1/MathJax.js?config=/corehtml/pmc/js/mathjax-config-classic.3.4.js"></script><script type="text/javascript">window.name="mainwindow";</script><style type="text/css">.pmc-wm {background:transparent repeat-y top left;background-image:url(/corehtml/pmc/pmcgifs/wm-hhspa.gif);background-size: auto, contain}</style><style type="text/css">.print-view{display:block}</style><style type="text/css">
        div.pmc_para_cit li.highlight,
        div.pmc_para_cit li.highlight .one_line_source
        { background: #E0E0E0; }
        a.bibr.highlight { background: #E0E0E0; } 
      </style><meta name="cited_in_systematic_reviews" content=""><link rel="alternate" type="application/epub+zip" href="/pmc/articles/PMC3676425/epub/"><link rel="alternate" type="application/pdf" href="/pmc/articles/PMC3676425/pdf/nihms446094.pdf">

        <!-- Page meta end -->
    <link rel="shortcut icon" href="//www.ncbi.nlm.nih.gov/favicon.ico"><meta name="ncbi_phid" content="CE8CF48CDD4EE29100000000067C0439.m_8">
<meta name="referrer" content="origin-when-cross-origin"><link type="text/css" rel="stylesheet" href="//static.pubmed.gov/portal/portal3rc.fcgi/4160049/css/3852956/3985586/3808861/4121862/3974050/3917732/251717/4048120/3846471/14534/45193/4113719/3849091/3984811/3751656/4033350/3840896/3577051/3852958/3881636/3579733/4062871/12930/3964959/3855473/4047625/3854974/3854955/4076335/4128070/9685/3549676/3609192/3609193/3609213/3395586/4143404.css"><link type="text/css" rel="stylesheet" href="//static.pubmed.gov/portal/portal3rc.fcgi/4160049/css/3411343/3882866/4157116.css" media="print"><script async="1" src="https://www.google-analytics.com/analytics.js"></script><style type="text/css">.MathJax_Preview {color: #888}
#MathJax_Message {position: fixed; left: 1px; bottom: 2px; background-color: #E6E6E6; border: 1px solid #959595; margin: 0px; padding: 2px 8px; z-index: 102; color: black; font-size: 80%; width: auto; white-space: nowrap}
#MathJax_MSIE_Frame {position: absolute; top: 0; left: 0; width: 0px; z-index: 101; border: 0px; margin: 0px; padding: 0px}
.MathJax_Error {color: #CC0000; font-style: italic}
</style><style type="text/css">.MathJax_Hover_Frame {border-radius: .25em; -webkit-border-radius: .25em; -moz-border-radius: .25em; -khtml-border-radius: .25em; box-shadow: 0px 0px 15px #83A; -webkit-box-shadow: 0px 0px 15px #83A; -moz-box-shadow: 0px 0px 15px #83A; -khtml-box-shadow: 0px 0px 15px #83A; border: 1px solid #A6D ! important; display: inline-block; position: absolute}
.MathJax_Menu_Button .MathJax_Hover_Arrow {position: absolute; cursor: pointer; display: inline-block; border: 2px solid #AAA; border-radius: 4px; -webkit-border-radius: 4px; -moz-border-radius: 4px; -khtml-border-radius: 4px; font-family: 'Courier New',Courier; font-size: 9px; color: #F0F0F0}
.MathJax_Menu_Button .MathJax_Hover_Arrow span {display: block; background-color: #AAA; border: 1px solid; border-radius: 3px; line-height: 0; padding: 4px}
.MathJax_Hover_Arrow:hover {color: white!important; border: 2px solid #CCC!important}
.MathJax_Hover_Arrow:hover span {background-color: #CCC!important}
</style><style type="text/css">#MathJax_Zoom {position: absolute; background-color: #F0F0F0; overflow: auto; display: block; z-index: 301; padding: .5em; border: 1px solid black; margin: 0; font-weight: normal; font-style: normal; text-align: left; text-indent: 0; text-transform: none; line-height: normal; letter-spacing: normal; word-spacing: normal; word-wrap: normal; white-space: nowrap; float: none; -webkit-box-sizing: content-box; -moz-box-sizing: content-box; box-sizing: content-box; box-shadow: 5px 5px 15px #AAAAAA; -webkit-box-shadow: 5px 5px 15px #AAAAAA; -moz-box-shadow: 5px 5px 15px #AAAAAA; -khtml-box-shadow: 5px 5px 15px #AAAAAA; filter: progid:DXImageTransform.Microsoft.dropshadow(OffX=2, OffY=2, Color='gray', Positive='true')}
#MathJax_ZoomOverlay {position: absolute; left: 0; top: 0; z-index: 300; display: inline-block; width: 100%; height: 100%; border: 0; padding: 0; margin: 0; background-color: white; opacity: 0; filter: alpha(opacity=0)}
#MathJax_ZoomFrame {position: relative; display: inline-block; height: 0; width: 0}
#MathJax_ZoomEventTrap {position: absolute; left: 0; top: 0; z-index: 302; display: inline-block; border: 0; padding: 0; margin: 0; background-color: white; opacity: 0; filter: alpha(opacity=0)}
</style><style type="text/css">#MathJax_About {position: fixed; left: 50%; width: auto; text-align: center; border: 3px outset; padding: 1em 2em; background-color: #DDDDDD; color: black; cursor: default; font-family: message-box; font-size: 120%; font-style: normal; text-indent: 0; text-transform: none; line-height: normal; letter-spacing: normal; word-spacing: normal; word-wrap: normal; white-space: nowrap; float: none; z-index: 201; border-radius: 15px; -webkit-border-radius: 15px; -moz-border-radius: 15px; -khtml-border-radius: 15px; box-shadow: 0px 10px 20px #808080; -webkit-box-shadow: 0px 10px 20px #808080; -moz-box-shadow: 0px 10px 20px #808080; -khtml-box-shadow: 0px 10px 20px #808080; filter: progid:DXImageTransform.Microsoft.dropshadow(OffX=2, OffY=2, Color='gray', Positive='true')}
#MathJax_About.MathJax_MousePost {outline: none}
.MathJax_Menu {position: absolute; background-color: white; color: black; width: auto; padding: 5px 0px; border: 1px solid #CCCCCC; margin: 0; cursor: default; font: menu; text-align: left; text-indent: 0; text-transform: none; line-height: normal; letter-spacing: normal; word-spacing: normal; word-wrap: normal; white-space: nowrap; float: none; z-index: 201; border-radius: 5px; -webkit-border-radius: 5px; -moz-border-radius: 5px; -khtml-border-radius: 5px; box-shadow: 0px 10px 20px #808080; -webkit-box-shadow: 0px 10px 20px #808080; -moz-box-shadow: 0px 10px 20px #808080; -khtml-box-shadow: 0px 10px 20px #808080; filter: progid:DXImageTransform.Microsoft.dropshadow(OffX=2, OffY=2, Color='gray', Positive='true')}
.MathJax_MenuItem {padding: 1px 2em; background: transparent}
.MathJax_MenuArrow {position: absolute; right: .5em; padding-top: .25em; color: #666666; font-size: .75em}
.MathJax_MenuActive .MathJax_MenuArrow {color: white}
.MathJax_MenuArrow.RTL {left: .5em; right: auto}
.MathJax_MenuCheck {position: absolute; left: .7em}
.MathJax_MenuCheck.RTL {right: .7em; left: auto}
.MathJax_MenuRadioCheck {position: absolute; left: .7em}
.MathJax_MenuRadioCheck.RTL {right: .7em; left: auto}
.MathJax_MenuLabel {padding: 1px 2em 3px 1.33em; font-style: italic}
.MathJax_MenuRule {border-top: 1px solid #DDDDDD; margin: 4px 3px}
.MathJax_MenuDisabled {color: GrayText}
.MathJax_MenuActive {background-color: #606872; color: white}
.MathJax_MenuDisabled:focus, .MathJax_MenuLabel:focus {background-color: #E8E8E8}
.MathJax_ContextMenu:focus {outline: none}
.MathJax_ContextMenu .MathJax_MenuItem:focus {outline: none}
#MathJax_AboutClose {top: .2em; right: .2em}
.MathJax_Menu .MathJax_MenuClose {top: -10px; left: -10px}
.MathJax_MenuClose {position: absolute; cursor: pointer; display: inline-block; border: 2px solid #AAA; border-radius: 18px; -webkit-border-radius: 18px; -moz-border-radius: 18px; -khtml-border-radius: 18px; font-family: 'Courier New',Courier; font-size: 24px; color: #F0F0F0}
.MathJax_MenuClose span {display: block; background-color: #AAA; border: 1.5px solid; border-radius: 18px; -webkit-border-radius: 18px; -moz-border-radius: 18px; -khtml-border-radius: 18px; line-height: 0; padding: 8px 0 6px}
.MathJax_MenuClose:hover {color: white!important; border: 2px solid #CCC!important}
.MathJax_MenuClose:hover span {background-color: #CCC!important}
.MathJax_MenuClose:hover:focus {outline: none}
</style></head>
    <body class="article" id="ui-ncbiexternallink-4"><div id="MathJax_Message" style="display: none;"></div>
        <div class="grid">
            <div class="col twelve_col nomargin shadow">
                <!-- System messages like service outage or JS required; this is handled by the TemplateResources portlet -->
                <div class="sysmessages">
                    <noscript>
	<p class="nojs">
	<strong>Warning:</strong>
	The NCBI web site requires JavaScript to function. 
	<a href="/guide/browsers/#enablejs" title="Learn how to enable JavaScript" target="_blank">more...</a>
	</p>
	</noscript>
                </div>
                <!--/.sysmessage-->
                <div class="wrap">
                    <div class="page">
                        <div class="top">
                            <div class="universal_header" id="universal_header"><ul class="inline_list jig-ncbimenu ui-ncbimenu resources_list ui-ncbibasicmenu orientation_hort" id="navcontent" role="menubar"><li class="ui-ncbimenu-item-leaf ui-ncbimenu-item-first ui-helper-reset ui-ncbimenu-item-no-hlt" role="presentation"><a class="ui-ncbimenu-link-first" href="/" role="menuitem" title="NCBI Home" id="ncbihome" accesskey="1"><span class="offscreen_noflow">NCBI</span><img src="//static.pubmed.gov/portal/portal3rc.fcgi/4160049/img/28977" class="ncbi_logo" title="NCBI" alt="NCBI Logo"></a></li><li class="offscreen_noflow ui-ncbimenu-item-skip access"><a href="#maincontent" title="Skip to the content" tabindex="0" accesskey="3">Skip to main
                        content</a></li><li class="offscreen_noflow ui-ncbimenu-item-skip access"><a href="#navcontent" title="Skip to the navigation" tabindex="0" accesskey="4">Skip to
                        navigation</a></li><li id="resource-menu" class="topmenu ui-helper-reset ui-ncbimenu-item-first ui-helper-reset" role="presentation"><a class="ui-ncbimenu-first-link-has-submenu ui-ncbimenu-link-first topanchor expandDown" href="/static/header_footer_ajax/submenu/#resources" tabindex="-1" role="menuitem">Resources</a></li><li id="all-howtos-menu" class="topmenu ui-helper-reset ui-ncbimenu-item-first" role="presentation"><a class="ui-ncbimenu-first-link-has-submenu ui-ncbimenu-link-first topanchor expandDown" href="/static/header_footer_ajax/submenu/#howto" tabindex="-1" role="menuitem">How To</a></li><li class="offscreen_noflow ui-ncbimenu-item-skip access"><a href="/guide/browsers/#accesskeys" title="About My NCBI Accesskeys" tabindex="0" accesskey="0">About NCBI Accesskeys</a></li></ul><div class="myncbi" style="top: -0.4em;"><iframe src="https://eutils.ncbi.nlm.nih.gov/entrez/eutils/emyncbi.fcgi?cmd=htmlportal&amp;currenturl=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC3676425%2F" style="border:none; height:2.5em; width:40em;" scrolling="no"></iframe></div></div>
                            <div class="header">
    <div class="res_logo">
  <h1 class="img_logo"><a href="/pmc/" class="pmc_logo offscreen">PMC</a></h1>
  <div class="NLMLogo">
    <a href="https://www.nlm.nih.gov/" title="US National Library of Medicine">US National Library of Medicine</a>
    <br>
    <a href="https://www.nih.gov/" title="National Institutes of Health">National Institutes of Health</a>
  </div>
</div>
    <div class="search"><form method="get" action="/pmc/"><div class="search_form"><label for="database" class="offscreen_noflow">Search database</label><select id="database"><optgroup label="Recent"><option value="pmc" selected="selected" class="last" data-ac_dict="pmc-search-autocomplete">PMC</option></optgroup><optgroup label="All"><option value="gquery">All Databases</option><option value="assembly">Assembly</option><option value="biocollections">Biocollections</option><option value="bioproject">BioProject</option><option value="biosample">BioSample</option><option value="biosystems">BioSystems</option><option value="books">Books</option><option value="clinvar">ClinVar</option><option value="cdd">Conserved Domains</option><option value="gap">dbGaP</option><option value="dbvar">dbVar</option><option value="gene">Gene</option><option value="genome">Genome</option><option value="gds">GEO DataSets</option><option value="geoprofiles">GEO Profiles</option><option value="gtr">GTR</option><option value="homologene">HomoloGene</option><option value="ipg">Identical Protein Groups</option><option value="medgen">MedGen</option><option value="mesh">MeSH</option><option value="ncbisearch">NCBI Web Site</option><option value="nlmcatalog">NLM Catalog</option><option value="nuccore">Nucleotide</option><option value="omim">OMIM</option><option value="pmc" data-ac_dict="pmc-search-autocomplete">PMC</option><option value="popset">PopSet</option><option value="probe">Probe</option><option value="protein">Protein</option><option value="proteinclusters">Protein Clusters</option><option value="pcassay">PubChem BioAssay</option><option value="pccompound">PubChem Compound</option><option value="pcsubstance">PubChem Substance</option><option value="pubmed">PubMed</option><option value="snp">SNP</option><option value="sparcle">Sparcle</option><option value="sra">SRA</option><option value="structure">Structure</option><option value="taxonomy">Taxonomy</option><option value="toolkit">ToolKit</option><option value="toolkitall">ToolKitAll</option><option value="toolkitbookgh">ToolKitBookgh</option></optgroup></select><div class="nowrap"><label for="term" class="offscreen_noflow" accesskey="/">Search term</label><div class="nowrap"><div class="jig-ncbiclearbutton-wrap ui-ncbiclearbutton-wrap box-shadow"><input name="term" id="term" title="Search PMC. Use up and down arrows to choose an item from the autocomplete." value="" class="jig-ncbiclearbutton jig-ncbiautocomplete" data-jigconfig="dictionary:'pmc-search-autocomplete',disableUrl:'NcbiSearchBarAutoComplCtrl'" autocomplete="off" data-sbconfig="ds:'no',pjs:'no',afs:'yes'" aria-haspopup="true" aria-autocomplete="list" role="textbox" type="text"><a class="reset" href="#" style="visibility: hidden;"><img src="/core/jig/1.14.8/img/clear.png" alt="Clear input"></a></div></div><button id="search" type="submit" class="button_search nowrap" cmd="go">Search</button></div></div></form><ul class="searchlinks inline_list"><li>
                        <a href="/pmc/advanced/">Advanced</a>
                    </li><li>
                        <a href="/pmc/journals/">Journal list</a>
                    </li><li class="help">
                        <a target="_blank" href="/books/NBK3825/">Help</a>
                    </li></ul></div>
</div>

                            
                            
                        <!--<component id="Page" label="headcontent"/>-->
                            
                        </div>
                        <div class="content">
                            <!-- site messages -->
                            <div class="container">
    <div id="maincontent" class="content eight_col col">
        <div class="navlink-box">
            <ul class="page-breadcrumbs inline_list small"><li class="journal-list"><a href="/pmc/journals/" class="navlink">Journal List</a></li><li class="article-entrez-filter"><a href="/pmc/?term=hhs%20author%20manuscript[filter]" class="navlink">HHS Author Manuscripts</a></li><li class="accid">PMC3676425</li></ul>
        </div>

        <!-- Journal banner -->
        <div class="pmc-page-banner whole_rhythm"><div><img src="/corehtml/pmc/pmcgifs/logo-hhspa.png" alt="Logo of nihpa" usemap="#logo-imagemap"><map id="logo-imagemap" name="logo-imagemap"><area shape="rect" coords="0,57,255,75" alt="About Author manuscripts" title="About Author manuscripts" href="https://www.ncbi.nlm.nih.gov/pmc/about/authorms.html" ref="https://www.ncbi.nlm.nih.gov/pmc/about/authorms.html"><area shape="rect" coords="256,57,500,75" alt="Submit a manuscript" title="Submit a manuscript" href="https://www.nihms.nih.gov/" ref="reftype=publisher&amp;article-id=3676425&amp;issue-id=223738&amp;journal-id=319&amp;FROM=Article%7CBanner&amp;TO=Publisher%7COther%7CN/A" target="pmc_ext"><area shape="rect" coords="0,0,499,74" alt="HHS Public Access; Author Manuscript; Accepted for publication in peer reviewed journal;" title="HHS Public Access; Author Manuscript; Accepted for publication in peer reviewed journal;" href="https://www.ncbi.nlm.nih.gov/pmc/about/public-access/" ref="reftype=publisher&amp;article-id=3676425&amp;issue-id=223738&amp;journal-id=319&amp;FROM=Article%7CBanner&amp;TO=Publisher%7COther%7CN/A" target="pmc_ext"></map></div> </div>
        
        <!--component id='MainPortlet' label='search-reference'/-->
        
        <!-- Book content -->
        <div class="">
            
        
            
            <div class="hide-overflow article lit-style content pmc-wm slang-all page-box"><!--main-content--><div class="jig-ncbiinpagenav" data-jigconfig="smoothScroll: false, allHeadingLevels: ['h2'], headingExclude: ':hidden'" id="ui-ncbiinpagenav-1"><div class="fm-sec half_rhythm no_top_margin"><div class="fm-citation half_rhythm no_top_margin clearfix"><div class="inline_block eight_col va_top"><div><span role="menubar"><a href="#" role="menuitem" aria-expanded="false" aria-haspopup="true">Nat Genet</a></span>. Author manuscript; available in PMC 2013 Jun 7.</div><div></div><div>Published in final edited form as:</div><div style="margin-left:1em"><div class="fm-vol-iss-date"><a href="/entrez/eutils/elink.fcgi?dbfrom=pubmed&amp;retmode=ref&amp;cmd=prlinks&amp;id=19287384" target="pmc_ext" ref="reftype=publisher&amp;article-id=3676425&amp;issue-id=223738&amp;journal-id=319&amp;FROM=Article%7CFront%20Matter&amp;TO=Content%20Provider%7CArticle%7CRestricted%20Access"><span class="cit">Nat Genet. 2009 Apr; 41(4): 455–459. </span></a></div><span class="fm-vol-iss-date">Published online 2009 Mar 15. </span> <span class="doi">doi:&nbsp;<a href="//dx.doi.org/10.1038%2Fng.342" target="pmc_ext" ref="reftype=other&amp;article-id=3676425&amp;issue-id=223738&amp;journal-id=319&amp;FROM=Article%7CFront%20Matter&amp;TO=Content%20Provider%7CCrosslink%7CDOI">10.1038/ng.342</a></span></div></div><div class="inline_block four_col va_top show-overflow align_right"><div class="fm-citation-ids"><div class="fm-citation-pmcid"><span class="fm-citation-ids-label">PMCID: </span><span>PMC3676425</span></div><div class="fm-citation-manuscriptid"><span class="fm-citation-ids-label">NIHMSID: </span><span>NIHMS446094</span></div><div class="fm-citation-pmid">PMID: <a href="/pubmed/19287384">19287384</a></div></div></div></div><h1 class="content-title">A germline <em>JAK2</em> SNP is associated with predisposition to the development of <em>JAK2</em><sup>V617F</sup>-positive myeloproliferative neoplasms</h1><div class="half_rhythm"><div class="contrib-group fm-author"><a href="/pubmed/?term=Kilpivaara%20O%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=19287384" class="affpopup" co-rid="_co_idm140352127361744" co-class="co-affbox">Outi Kilpivaara</a>,<sup>1,</sup><sup>12</sup> <a href="/pubmed/?term=Mukherjee%20S%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=19287384" class="affpopup" co-rid="_co_idm140352115854896" co-class="co-affbox">Semanti Mukherjee</a>,<sup>2,</sup><sup>3,</sup><sup>12</sup> <a href="/pubmed/?term=Schram%20AM%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=19287384" class="affpopup" co-rid="_co_idm140352160592048" co-class="co-affbox">Alison M Schram</a>,<sup>1</sup> <a href="/pubmed/?term=Wadleigh%20M%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=19287384" class="affpopup" co-rid="_co_idm140352123139840" co-class="co-affbox">Martha Wadleigh</a>,<sup>4</sup> <a href="/pubmed/?term=Mullally%20A%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=19287384" class="affpopup" co-rid="_co_idm140352123137856" co-class="co-affbox">Ann Mullally</a>,<sup>4,</sup><sup>5</sup> <a href="/pubmed/?term=Ebert%20BL%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=19287384" class="affpopup" co-rid="_co_idm140352119018208" co-class="co-affbox">Benjamin L Ebert</a>,<sup>5,</sup><sup>6</sup> <a href="/pubmed/?term=Bass%20A%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=19287384" class="affpopup" co-rid="_co_idm140352123429552" co-class="co-affbox">Adam Bass</a>,<sup>4,</sup><sup>6</sup> <a href="/pubmed/?term=Marubayashi%20S%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=19287384" class="affpopup" co-rid="_co_idm140352125793712" co-class="co-affbox">Sachie Marubayashi</a>,<sup>1</sup> <a href="/pubmed/?term=Heguy%20A%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=19287384" class="affpopup" co-rid="_co_idm140352123862816" co-class="co-affbox">Adriana Heguy</a>,<sup>1</sup> <a href="/pubmed/?term=Garcia-Manero%20G%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=19287384" class="affpopup" co-rid="_co_idm140352123860832" co-class="co-affbox">Guillermo Garcia-Manero</a>,<sup>7</sup> <a href="/pubmed/?term=Kantarjian%20H%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=19287384" class="affpopup" co-rid="_co_idm140352114509472" co-class="co-affbox">Hagop Kantarjian</a>,<sup>7</sup> <a href="/pubmed/?term=Offit%20K%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=19287384" class="affpopup" co-rid="_co_idm140352127855152" co-class="co-affbox">Kenneth Offit</a>,<sup>8</sup> <a href="/pubmed/?term=Stone%20RM%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=19287384" class="affpopup" co-rid="_co_idm140352127853168" co-class="co-affbox">Richard M Stone</a>,<sup>4</sup> <a href="/pubmed/?term=Gilliland%20DG%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=19287384" class="affpopup" co-rid="_co_idm140352114549872" co-class="co-affbox">D Gary Gilliland</a>,<sup>4,</sup><sup>5,</sup><sup>6,</sup><sup>9,</sup><sup>10</sup> <a href="/pubmed/?term=Klein%20RJ%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=19287384" class="affpopup" co-rid="_co_idm140352119329872" co-class="co-affbox">Robert J Klein</a>,<sup>2</sup> and  <a href="/pubmed/?term=Levine%20RL%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=19287384" class="affpopup" co-rid="_co_idm140352123056880" co-class="co-affbox">Ross L Levine</a><sup>1,</sup><sup>11</sup></div><div style="display:none" class="contrib-group aff-tip"><div id="_co_idm140352127361744"><h3 class="no_margin">Outi Kilpivaara</h3><p><sup>1</sup>Human Oncology and Pathogenesis Program, Memorial Sloan-Kettering Cancer Center, New York, New York, USA</p><div>Find articles by <a href="/pubmed/?term=Kilpivaara%20O%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=19287384">Outi Kilpivaara</a></div></div><div id="_co_idm140352115854896"><h3 class="no_margin">Semanti Mukherjee</h3><p><sup>2</sup>Cancer Biology and Genetics Program, Memorial Sloan-Kettering Cancer Center, New York, New York, USA</p><p><sup>3</sup>Gerstner Sloan-Kettering Graduate School of Biomedical Sciences, New York, New York, USA</p><div>Find articles by <a href="/pubmed/?term=Mukherjee%20S%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=19287384">Semanti Mukherjee</a></div></div><div id="_co_idm140352160592048"><h3 class="no_margin">Alison M Schram</h3><p><sup>1</sup>Human Oncology and Pathogenesis Program, Memorial Sloan-Kettering Cancer Center, New York, New York, USA</p><div>Find articles by <a href="/pubmed/?term=Schram%20AM%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=19287384">Alison M Schram</a></div></div><div id="_co_idm140352123139840"><h3 class="no_margin">Martha Wadleigh</h3><p><sup>4</sup>Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts, USA</p><div>Find articles by <a href="/pubmed/?term=Wadleigh%20M%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=19287384">Martha Wadleigh</a></div></div><div id="_co_idm140352123137856"><h3 class="no_margin">Ann Mullally</h3><p><sup>4</sup>Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts, USA</p><p><sup>5</sup>Division of Hematology, Department of Medicine, Brigham and Women’s Hospital, Boston, Massachusetts, USA</p><div>Find articles by <a href="/pubmed/?term=Mullally%20A%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=19287384">Ann Mullally</a></div></div><div id="_co_idm140352119018208"><h3 class="no_margin">Benjamin L Ebert</h3><p><sup>5</sup>Division of Hematology, Department of Medicine, Brigham and Women’s Hospital, Boston, Massachusetts, USA</p><p><sup>6</sup>Broad Institute of Harvard and MIT, Cambridge, Massachusetts, USA</p><div>Find articles by <a href="/pubmed/?term=Ebert%20BL%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=19287384">Benjamin L Ebert</a></div></div><div id="_co_idm140352123429552"><h3 class="no_margin">Adam Bass</h3><p><sup>4</sup>Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts, USA</p><p><sup>6</sup>Broad Institute of Harvard and MIT, Cambridge, Massachusetts, USA</p><div>Find articles by <a href="/pubmed/?term=Bass%20A%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=19287384">Adam Bass</a></div></div><div id="_co_idm140352125793712"><h3 class="no_margin">Sachie Marubayashi</h3><p><sup>1</sup>Human Oncology and Pathogenesis Program, Memorial Sloan-Kettering Cancer Center, New York, New York, USA</p><div>Find articles by <a href="/pubmed/?term=Marubayashi%20S%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=19287384">Sachie Marubayashi</a></div></div><div id="_co_idm140352123862816"><h3 class="no_margin">Adriana Heguy</h3><p><sup>1</sup>Human Oncology and Pathogenesis Program, Memorial Sloan-Kettering Cancer Center, New York, New York, USA</p><div>Find articles by <a href="/pubmed/?term=Heguy%20A%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=19287384">Adriana Heguy</a></div></div><div id="_co_idm140352123860832"><h3 class="no_margin">Guillermo Garcia-Manero</h3><p><sup>7</sup>Department of Leukemia, M.D. Anderson Cancer Center, Houston, Texas, USA</p><div>Find articles by <a href="/pubmed/?term=Garcia-Manero%20G%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=19287384">Guillermo Garcia-Manero</a></div></div><div id="_co_idm140352114509472"><h3 class="no_margin">Hagop Kantarjian</h3><p><sup>7</sup>Department of Leukemia, M.D. Anderson Cancer Center, Houston, Texas, USA</p><div>Find articles by <a href="/pubmed/?term=Kantarjian%20H%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=19287384">Hagop Kantarjian</a></div></div><div id="_co_idm140352127855152"><h3 class="no_margin">Kenneth Offit</h3><p><sup>8</sup>Clinical Genetics Service, Department of Medicine, Memorial Sloan-Kettering Cancer Center, New York, New York, USA</p><div>Find articles by <a href="/pubmed/?term=Offit%20K%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=19287384">Kenneth Offit</a></div></div><div id="_co_idm140352127853168"><h3 class="no_margin">Richard M Stone</h3><p><sup>4</sup>Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts, USA</p><div>Find articles by <a href="/pubmed/?term=Stone%20RM%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=19287384">Richard M Stone</a></div></div><div id="_co_idm140352114549872"><h3 class="no_margin">D Gary Gilliland</h3><p><sup>4</sup>Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts, USA</p><p><sup>5</sup>Division of Hematology, Department of Medicine, Brigham and Women’s Hospital, Boston, Massachusetts, USA</p><p><sup>6</sup>Broad Institute of Harvard and MIT, Cambridge, Massachusetts, USA</p><p><sup>9</sup>Howard Hughes Medical Institute, Harvard Medical School, Boston, Massachusetts, USA</p><p><sup>10</sup>Harvard Stem Cell Institute, Boston, Massachusetts, USA</p><div>Find articles by <a href="/pubmed/?term=Gilliland%20DG%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=19287384">D Gary Gilliland</a></div></div><div id="_co_idm140352119329872"><h3 class="no_margin">Robert J Klein</h3><p><sup>2</sup>Cancer Biology and Genetics Program, Memorial Sloan-Kettering Cancer Center, New York, New York, USA</p><div>Find articles by <a href="/pubmed/?term=Klein%20RJ%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=19287384">Robert J Klein</a></div></div><div id="_co_idm140352123056880"><h3 class="no_margin">Ross L Levine</h3><p><sup>1</sup>Human Oncology and Pathogenesis Program, Memorial Sloan-Kettering Cancer Center, New York, New York, USA</p><p><sup>11</sup>Leukemia Service, Department of Medicine, Memorial Sloan-Kettering Cancer Center, New York, New York, USA</p><div>Find articles by <a href="/pubmed/?term=Levine%20RL%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=19287384">Ross L Levine</a></div></div></div></div><div class="fm-panel half_rhythm"><div class="togglers"><a href="#" class="pmctoggle" rid="idm140352111934848_ai">Author information</a> <a href="#" class="pmctoggle" rid="idm140352111934848_cpl">Copyright and License information</a> <a href="/pmc/about/disclaimer/">Disclaimer</a></div><div class="fm-authors-info fm-panel hide half_rhythm" id="idm140352111934848_ai" style="display:none"><div class="fm-affl" id="A1" lang="en"><sup>1</sup>Human Oncology and Pathogenesis Program, Memorial Sloan-Kettering Cancer Center, New York, New York, USA</div><div class="fm-affl" id="A2" lang="en"><sup>2</sup>Cancer Biology and Genetics Program, Memorial Sloan-Kettering Cancer Center, New York, New York, USA</div><div class="fm-affl" id="A3" lang="en"><sup>3</sup>Gerstner Sloan-Kettering Graduate School of Biomedical Sciences, New York, New York, USA</div><div class="fm-affl" id="A4" lang="en"><sup>4</sup>Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts, USA</div><div class="fm-affl" id="A5" lang="en"><sup>5</sup>Division of Hematology, Department of Medicine, Brigham and Women’s Hospital, Boston, Massachusetts, USA</div><div class="fm-affl" id="A6" lang="en"><sup>6</sup>Broad Institute of Harvard and MIT, Cambridge, Massachusetts, USA</div><div class="fm-affl" id="A7" lang="en"><sup>7</sup>Department of Leukemia, M.D. Anderson Cancer Center, Houston, Texas, USA</div><div class="fm-affl" id="A8" lang="en"><sup>8</sup>Clinical Genetics Service, Department of Medicine, Memorial Sloan-Kettering Cancer Center, New York, New York, USA</div><div class="fm-affl" id="A9" lang="en"><sup>9</sup>Howard Hughes Medical Institute, Harvard Medical School, Boston, Massachusetts, USA</div><div class="fm-affl" id="A10" lang="en"><sup>10</sup>Harvard Stem Cell Institute, Boston, Massachusetts, USA</div><div class="fm-affl" id="A11" lang="en"><sup>11</sup>Leukemia Service, Department of Medicine, Memorial Sloan-Kettering Cancer Center, New York, New York, USA</div><div id="FN1">Correspondence should be addressed to R.J.K. (<a href="mailto:dev@null" data-email="gro.ccksm@rnielk" class="oemail">gro.ccksm@rnielk</a>) or R.L.L. (<a href="mailto:dev@null" data-email="gro.ccksm@renivel" class="oemail">gro.ccksm@renivel</a>)</div><div id="FN2"><sup>12</sup>These authors contributed equally to this work.</div></div><div class="fm-article-notes fm-panel half_rhythm"></div><div class="permissions fm-panel half_rhythm hide" id="idm140352111934848_cpl" style="display:none"><div class="fm-copyright half_rhythm"><a href="/pmc/about/copyright/">Copyright notice</a> </div></div></div><div id="pmclinksbox" class="links-box whole_rhythm"><div class="fm-panel"><div>The publisher's final edited version of this article is available  at <a href="/entrez/eutils/elink.fcgi?dbfrom=pubmed&amp;retmode=ref&amp;cmd=prlinks&amp;id=19287384" target="pmc_ext" ref="reftype=publisher&amp;article-id=3676425&amp;issue-id=223738&amp;journal-id=319&amp;FROM=Article%7CFront%20Matter&amp;TO=Content%20Provider%7CArticle%7CRestricted%20Access">Nat Genet</a></div><div>See other articles in PMC that <a href="/pmc/articles/PMC3676425/citedby/">cite</a> the published article.</div></div></div></div><div class="sec"></div><div id="ass-data" class="tsec fm-sec whole_rhythm" data-section="Featured_PMC_Datacitation"><div class="goto jig-ncbiinpagenav-goto-container"><span role="menubar"><a class="tgt_dark page-toc-label jig-ncbiinpagenav-goto-heading" href="#" title="Go to other sections in this page" role="menuitem" aria-expanded="false" aria-haspopup="true">Go to:</a></span></div><h2 class="ui-helper-clearfix" id="ui-ncbiinpagenav-heading-3">Associated Data</h2><dl data-count="1" class="box-data-suppmats whole_rhythm no_bottom_margin"><dt><a href="#" rid="data-suppmats" data-ga-action="click_feat_toggler" data-ga-label="Supplementary Materials" class="pmctoggle">Supplementary Materials</a></dt><dd id="data-suppmats" style="display: none;"><div class="half_rhythm"><div class="caption half_rhythm no_bottom_margin"><strong>Supplements.</strong></div><div><a href="/pmc/articles/PMC3676425/bin/NIHMS446094-supplement-Supplements.pdf" data-ga-action="click_feat_suppl">NIHMS446094-supplement-Supplements.pdf</a><span style="color:gray"> (336K)</span></div><div class="small guid">GUID:&nbsp;2DAA2F89-F2FE-431C-A34E-346D08FB1DC2</div></div></dd></dl></div><div id="idm140352125432944" class="tsec sec" lang="en"><div class="goto jig-ncbiinpagenav-goto-container"><a class="tgt_dark page-toc-label jig-ncbiinpagenav-goto-heading" href="#" title="Go to other sections in this page" role="button" aria-expanded="false" aria-haspopup="true">Go to:</a></div><h2 class="head no_bottom_margin ui-helper-clearfix" id="idm140352125432944title">Abstract</h2><!--article-meta--><div><p id="P1" class="p p-first-last">Polycythemia vera, essential thrombocythemia and primary myelofibrosis are myeloproliferative neoplasms (MPN) characterized by multilineage clonal hematopoiesis<sup><a href="#R1" rid="R1" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_318236050">1</a>–<a href="#R5" rid="R5" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_318236044">5</a></sup>. Given that the identical somatic activating mutation in the <em>JAK2</em> tyrosine kinase gene (<em>JAK2</em><sup>V617F</sup>) is observed in most individuals with polycythemia vera, essential thrombocythemia and primary myelofibrosis<sup><a href="#R6" rid="R6" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_318236046">6</a>–<a href="#R10" rid="R10" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_318236029">10</a></sup>, there likely are additional genetic events that contribute to the pathogenesis of these phenotypically distinct disorders. Moreover, family members of individuals with MPN are at higher risk for the development of MPN, consistent with the existence of MPN predisposition loci<sup><a href="#R11" rid="R11" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_318236042">11</a></sup>. We hypothesized that germline variation contributes to MPN predisposition and phenotypic pleiotropy. Genome-wide analysis identified an allele in the <em>JAK2</em> locus (rs10974944) that predisposes to the development of <em>JAK2</em><sup>V617F</sup>-positive MPN, as well as three previously unknown MPN modifier loci. We found that <em>JAK2</em><sup>V617F</sup> is preferentially acquired in cis with the predisposition allele. These data suggest that germline variation is an important contributor to MPN phenotype and predisposition.</p></div></div><div id="idm140352195379520" class="tsec sec headless whole_rhythm"><p id="P2" class="p p-first">The presence of the identical <em>JAK2</em><sup>V617F</sup> allele in polycythemia vera, essential thrombocythemia and primary myelofibrosis suggests that there are additional genetic and epigenetic events that contribute to MPN pathogenesis. To date, most studies have focused on the identification of additional somatic events that are stochastically acquired by the MPN clone, whereas few studies have addressed the role of germline genetic variation in MPN pathogenesis. A recent analysis of 32 candidate SNPs in MPN tumor samples identified three SNPs in <em>JAK2</em> that were enriched in polycythemia vera<sup><a href="#R12" rid="R12" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_318236036">12</a></sup>; although these results suggest there are host genetic variants that influence MPN phenotype, the findings are likely influenced by the high rate of somatic isodisomy at the <em>JAK2</em> locus in polycythemia vera. It has also been observed that there is familial clustering in MPN cases<sup><a href="#R13" rid="R13" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_318236053">13</a>–<a href="#R15" rid="R15" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_318236026">15</a></sup>, suggesting that there are inherited MPN predisposition loci. We therefore used genome-wide SNP array data to identify MPN modifier and predisposition loci.</p><p id="P3">We first analyzed Affymetrix <em>StyI</em> SNP array data derived from granulocyte DNA from 181 subjects with polycythemia vera or essential thrombocythemia to identify loci significantly enriched in these conditions. We identified four loci with P values &lt; 10<sup>–5</sup>, including SNPs at three loci not previously implicated in either disease (<a href="/pmc/articles/PMC3676425/table/T1/" target="table" class="fig-table-link figpopup" rid-figpopup="T1" rid-ob="ob-T1" co-legend-rid=""><span>Table 1</span></a>). We confirmed that the minor allele at rs12500918 is more common in polycythemia vera than in essential thrombo<strong>-</strong> cythemia in a larger set of MPN samples (P = 0.01). Unbiased genome-wide analysis also suggested that germline variation at the <em>JAK2</em> locus (rs10974944) varied according to MPN phenotype. However, given acquired isodisomy leading to homozygosity for <em>JAK2</em><sup>V617F</sup> is more common in polycythemia vera than in essential thrombocythemia, we were concerned that individuals with poly-cythemia vera might have a spuriously high prevalence of the minor allele (G) owing to somatic alterations at the <em>JAK2</em> locus<sup><a href="#R6" rid="R6" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_318236045">6</a>–<a href="#R8" rid="R8" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_318236025">8</a>,<a href="#R10" rid="R10" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_318236034">10</a>,<a href="#R16" rid="R16" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_318236035">16</a></sup>. To exclude the effects of somatic variation at the <em>JAK2</em> locus, we analyzed germline DNA samples from 284 subjects with polycythe-mia vera or essential thrombocythemia for <em>JAK2</em> SNP rs10974944 and confirmed that the minor allele (G) was significantly more common in polycythemia vera than in essential thrombocythemia (P = 0.01).</p><!--table ft1--><!--table-wrap mode="anchored" t5--><div class="table-wrap table anchored whole_rhythm" id="T1"><h3>Table 1</h3><!--caption a7--><div class="caption"><p id="__p8">Candidate modifier loci identified in genome-wide SNP array analysis</p></div><div data-largeobj="" data-largeobj-link-rid="largeobj_idm140352120139152" class="xtable"><table frame="hsides" rules="groups" class="rendered small default_table"><thead><tr><th rowspan="1" colspan="1" valign="top" align="left">SNP</th><th rowspan="1" colspan="1" valign="top" align="left">Chromosomal locus (gene)</th><th rowspan="1" colspan="1" valign="top" align="left">Genetic model</th><th rowspan="1" colspan="1" valign="top" align="center">P value (unadjusted)</th><th rowspan="1" colspan="1" valign="top" align="center">Permutation P value</th><th rowspan="1" colspan="1" valign="top" align="center">Odds ratio (95% CI)</th></tr></thead><tbody><tr><td rowspan="1" colspan="1" valign="top" align="left">rs12500918</td><td rowspan="1" colspan="1" valign="top" align="left">4q31</td><td rowspan="1" colspan="1" valign="top" align="left">Allelic</td><td rowspan="1" colspan="1" valign="top" align="center">1.0 × 10<sup>–7</sup></td><td rowspan="1" colspan="1" valign="top" align="center">1.0 × 10<sup>–7</sup></td><td rowspan="1" colspan="1" valign="top" align="center">3.6 (2.0–6.3)</td></tr><tr><td rowspan="1" colspan="1" valign="top" align="left">rs1524395</td><td rowspan="1" colspan="1" valign="top" align="left">7p11</td><td rowspan="1" colspan="1" valign="top" align="left">Allelic</td><td rowspan="1" colspan="1" valign="top" align="center">4.4 × 10<sup>–6</sup></td><td rowspan="1" colspan="1" valign="top" align="center">8.3 × 10<sup>–6</sup></td><td rowspan="1" colspan="1" valign="top" align="center">3.4 (2.0–6.0)</td></tr><tr><td rowspan="1" colspan="1" valign="top" align="left">rs10974944</td><td rowspan="1" colspan="1" valign="top" align="left">9p24 (JAK2)</td><td rowspan="1" colspan="1" valign="top" align="left">Genotypic</td><td rowspan="1" colspan="1" valign="top" align="center">2.5 × 10<sup>–7</sup></td><td rowspan="1" colspan="1" valign="top" align="center">9.7 × 10<sup>–6</sup></td><td rowspan="1" colspan="1" valign="top" align="center">1.9 (1.2–2.7)</td></tr><tr><td rowspan="1" colspan="1" valign="top" align="left">rs2279784</td><td rowspan="1" colspan="1" valign="top" align="left">3q21 (KALRN)</td><td rowspan="1" colspan="1" valign="top" align="left">Trend</td><td rowspan="1" colspan="1" valign="top" align="center">1.5 × 10<sup>5</sup></td><td rowspan="1" colspan="1" valign="top" align="center">1.0 × 10<sup>–5</sup></td><td rowspan="1" colspan="1" valign="top" align="center">7.4 (2.8–20)</td></tr><tr><td colspan="6" rowspan="1" valign="bottom" align="left">
<hr></td></tr><tr><td colspan="2" rowspan="1" valign="top" align="left">rs12500918 genotype</td><td colspan="2" rowspan="1" valign="top" align="center">PV</td><td colspan="2" rowspan="1" valign="top" align="center">ET</td></tr><tr><td colspan="6" rowspan="1" valign="bottom" align="left">
<hr></td></tr><tr><td colspan="2" rowspan="1" valign="top" align="left">AA</td><td colspan="2" rowspan="1" valign="top" align="center">50 (38.8%)</td><td colspan="2" rowspan="1" valign="top" align="center">29 (24.4%)</td></tr><tr><td colspan="2" rowspan="1" valign="top" align="left">AC</td><td colspan="2" rowspan="1" valign="top" align="center">64 (49.6%)</td><td colspan="2" rowspan="1" valign="top" align="center">63 (52.9%)</td></tr><tr><td colspan="2" rowspan="1" valign="top" align="left">CC</td><td colspan="2" rowspan="1" valign="top" align="center">15 (11.6%)</td><td colspan="2" rowspan="1" valign="top" align="center">27 (22.7%)</td></tr><tr><td colspan="2" rowspan="1" valign="top" align="left"></td><td colspan="2" rowspan="1" valign="top" align="center"></td><td colspan="2" rowspan="1" valign="top" align="center"><em>P</em> = 0.0134</td></tr><tr><td colspan="6" rowspan="1" valign="bottom" align="left">
<hr></td></tr><tr><td colspan="2" rowspan="1" valign="top" align="left">Germline rs10974944 genotype</td><td colspan="2" rowspan="1" valign="top" align="center">PV</td><td colspan="2" rowspan="1" valign="top" align="center">ET</td></tr><tr><td colspan="6" rowspan="1" valign="bottom" align="left">
<hr></td></tr><tr><td colspan="2" rowspan="1" valign="top" align="left">GG</td><td colspan="2" rowspan="1" valign="top" align="center">44 (26.7%)</td><td colspan="2" rowspan="1" valign="top" align="center">19 (16.0%)</td></tr><tr><td colspan="2" rowspan="1" valign="top" align="left">CG</td><td colspan="2" rowspan="1" valign="top" align="center">84 (50.9%)</td><td colspan="2" rowspan="1" valign="top" align="center">56 (47.1%)</td></tr><tr><td colspan="2" rowspan="1" valign="top" align="left">CC</td><td colspan="2" rowspan="1" valign="top" align="center">37 (22.4%)</td><td colspan="2" rowspan="1" valign="top" align="center">44 (37.0%)</td></tr><tr><td colspan="2" rowspan="1" valign="top" align="left"></td><td colspan="2" rowspan="1" valign="top" align="center"></td><td colspan="2" rowspan="1" valign="top" align="center"><em>P</em> = 0.011</td></tr></tbody></table></div><div id="largeobj_idm140352120139152" class="largeobj-link align_right" style=""><a target="object" href="/pmc/articles/PMC3676425/table/T1/?report=objectonly">Open in a separate window</a></div><div class="tblwrap-foot"><div id="TFN1"><p id="__p9" class="p p-first-last">PV, polycythemia vera; ET, essential thrombocythemia.</p></div></div></div><p id="P4">We also noted that the frequency of the GG/CG genotypes at rs10974944 was much higher in MPN cases than in control populations, suggesting that rs10974944 is a MPN predisposition allele. Analysis of germline DNA from 324 subjects with polycythemia vera, essential thrombocythemia and primary myelofibrosis found that the GG/CG genotypes at rs10974944 were more common in MPN cases compared to WTCCC controls (OR = 3.1, P = 4.1 × 10<sup>–20</sup>; <a href="/pmc/articles/PMC3676425/table/T2/" target="table" class="fig-table-link figpopup" rid-figpopup="T2" rid-ob="ob-T2" co-legend-rid=""><span>Table 2</span></a>), consistent with the G allele functioning as a dominant MPN predisposition allele. These data indicate that germline <em>JAK2</em> variation more strongly influences MPN predisposition than MPN phenotype. In contrast, allelic variation at rs12500918 is associated with MPN phenotype (P = 0.01) but not with MPN predisposition (P = 0.24) (<a href="#SD1" rid="SD1" class=" supplementary-material">Supplementary Table 1</a> online).</p><!--table ft1--><!--table-wrap mode="anchored" t5--><div class="table-wrap table anchored whole_rhythm" id="T2"><h3>Table 2</h3><!--caption a7--><div class="caption"><p id="__p10">Germline genotype for <em>JAK2</em> SNP rs10974944 in MPN cases and WTCCC controls</p></div><div data-largeobj="" data-largeobj-link-rid="largeobj_idm140352120247552" class="xtable"><table frame="hsides" rules="groups" class="rendered small default_table"><thead><tr><th colspan="3" rowspan="1" valign="top" align="left">(a) Germline genotype for <em>JAK2</em> SNP rs10974944 and MPN predisposition</th></tr><tr><th colspan="3" rowspan="1" valign="bottom" align="left">
<hr></th></tr><tr><th rowspan="1" colspan="1" valign="top" align="left">rs10974944 genotype</th><th rowspan="1" colspan="1" valign="top" align="center">MPN</th><th rowspan="1" colspan="1" valign="top" align="center">WTCCC</th></tr></thead><tbody><tr><td rowspan="1" colspan="1" valign="top" align="left">GG</td><td rowspan="1" colspan="1" valign="top" align="center">70 (21.6%)</td><td rowspan="1" colspan="1" valign="top" align="center">195 (6.5%)</td></tr><tr><td rowspan="1" colspan="1" valign="top" align="left">CG</td><td rowspan="1" colspan="1" valign="top" align="center">161 (49.7%)</td><td rowspan="1" colspan="1" valign="top" align="center">1,139 (38.0%)</td></tr><tr><td rowspan="1" colspan="1" valign="top" align="left">CC</td><td rowspan="1" colspan="1" valign="top" align="center">93 (28.7%)</td><td rowspan="1" colspan="1" valign="top" align="center">1,665 (55.5%)</td></tr><tr><td colspan="3" rowspan="1" valign="bottom" align="left">
<hr></td></tr><tr><td rowspan="1" colspan="1" valign="top" align="left"></td><td rowspan="1" colspan="1" valign="top" align="center"><em>P</em></td><td rowspan="1" colspan="1" valign="top" align="center">OR (95% CI)</td></tr><tr><td colspan="3" rowspan="1" valign="bottom" align="left">
<hr></td></tr><tr><td rowspan="1" colspan="1" valign="top" align="left">GG vs. CG/CC</td><td rowspan="1" colspan="1" valign="top" align="center">1.5 × 10<sup>–21</sup></td><td rowspan="1" colspan="1" valign="top" align="center">4.0 (2.9–5.4)</td></tr><tr><td rowspan="1" colspan="1" valign="top" align="left">GG/CG vs. CC</td><td rowspan="1" colspan="1" valign="top" align="center">4.1 × 10<sup>–20</sup></td><td rowspan="1" colspan="1" valign="top" align="center">3.1 (2.4–4.0)</td></tr><tr><td rowspan="1" colspan="1" valign="top" align="left">GG vs. CC</td><td rowspan="1" colspan="1" valign="top" align="center">5.1 × 10<sup>–32</sup></td><td rowspan="1" colspan="1" valign="top" align="center">6.4 (4.6–9.1)</td></tr><tr><td rowspan="1" colspan="1" valign="top" align="left">CG vs. CC</td><td rowspan="1" colspan="1" valign="top" align="center">2.1 × 10<sup>–12</sup></td><td rowspan="1" colspan="1" valign="top" align="center">2.5 (1.9–3.3)</td></tr><tr><td colspan="3" rowspan="1" valign="bottom" align="left">
<hr></td></tr><tr><td colspan="3" rowspan="1" valign="top" align="left">(b) Germline genotype for <em>JAK2</em> SNP rs10974944 in MPN cases and matched WTCCC controls according to principal component analysis</td></tr><tr><td rowspan="1" colspan="1" valign="top" align="left">rs10974944 genotype</td><td rowspan="1" colspan="1" valign="top" align="center">MPN</td><td rowspan="1" colspan="1" valign="top" align="center">WTCCC</td></tr><tr><td colspan="3" rowspan="1" valign="bottom" align="left">
<hr></td></tr><tr><td rowspan="1" colspan="1" valign="top" align="left">GG</td><td rowspan="1" colspan="1" valign="top" align="center">18 (20.5%)</td><td rowspan="1" colspan="1" valign="top" align="center">192 (6.5%)</td></tr><tr><td rowspan="1" colspan="1" valign="top" align="left">CG</td><td rowspan="1" colspan="1" valign="top" align="center">44 (50.0%)</td><td rowspan="1" colspan="1" valign="top" align="center">1,121 (37.9%)</td></tr><tr><td rowspan="1" colspan="1" valign="top" align="left">CC</td><td rowspan="1" colspan="1" valign="top" align="center">26 (29.5%)</td><td rowspan="1" colspan="1" valign="top" align="center">1,646 (55.6%)</td></tr><tr><td colspan="3" rowspan="1" valign="bottom" align="left">
<hr></td></tr><tr><td rowspan="1" colspan="1" valign="top" align="left"></td><td rowspan="1" colspan="1" valign="top" align="center"><em>P</em></td><td rowspan="1" colspan="1" valign="top" align="center">OR (95% CI)</td></tr><tr><td colspan="3" rowspan="1" valign="bottom" align="left">
<hr></td></tr><tr><td rowspan="1" colspan="1" valign="top" align="left">GG vs. CG/CC</td><td rowspan="1" colspan="1" valign="top" align="center">3.5 × 10<sup>–07</sup></td><td rowspan="1" colspan="1" valign="top" align="center">3.7 (2.2–6.3)</td></tr><tr><td rowspan="1" colspan="1" valign="top" align="left">GG/CG vs. CC</td><td rowspan="1" colspan="1" valign="top" align="center">1.3 × 10<sup>–06</sup></td><td rowspan="1" colspan="1" valign="top" align="center">3.0 (1.9–4.8)</td></tr><tr><td rowspan="1" colspan="1" valign="top" align="left">GG vs. CC</td><td rowspan="1" colspan="1" valign="top" align="center">2.3 × 10<sup>–10</sup></td><td rowspan="1" colspan="1" valign="top" align="center">5.9 (3.2–11.0)</td></tr><tr><td rowspan="1" colspan="1" valign="top" align="left">CG vs. CC</td><td rowspan="1" colspan="1" valign="top" align="center">0.00017</td><td rowspan="1" colspan="1" valign="top" align="center">2.5 (1.5–4.2)</td></tr></tbody></table></div><div id="largeobj_idm140352120247552" class="largeobj-link align_right" style=""><a target="object" href="/pmc/articles/PMC3676425/table/T2/?report=objectonly">Open in a separate window</a></div></div><p id="P5">We then carried out principal component analysis of SNP array data derived from MPN samples and WTCCC controls to assess whether population substructure or ancestry might explain differences in rs10974944 allele frequency. We selected case and control individuals who cluster on the first two principal components consistent with ancestry from Northern and Western Europe (<a href="/pmc/articles/PMC3676425/figure/F1/" target="figure" class="fig-table-link figpopup" rid-figpopup="F1" rid-ob="ob-F1" co-legend-rid="lgnd_F1"><span>Fig. 1</span></a>). We observed a similar relationship between genotypic variation at <em>JAK2</em> and MPN predisposition in these matched cases and controls, suggesting that differences in the frequency of rs10974944 genotypes are not due to differences in population substructure. Moreover, the distribution of rs10974944 genotypes did not vary in eight different ancestry populations (<a href="#SD1" rid="SD1" class=" supplementary-material">Supplementary Fig. 1a</a> online), or in myelodysplasia (P = 0.23) or acute myeloid leukemia (P = 0.10) samples compared to control samples (<a href="#SD1" rid="SD1" class=" supplementary-material">Supplementary Fig. 1b</a>).</p><!--fig ft0--><!--fig mode=article f1--><div class="fig iconblock whole_rhythm clearfix" id="F1" co-legend-rid="lgnd_F1"><a href="/pmc/articles/PMC3676425/figure/F1/" target="figure" rid-figpopup="F1" rid-ob="ob-F1"><!--fig/graphic|fig/alternatives/graphic mode="anchored" m1--><div data-largeobj="" data-largeobj-link-rid="largeobj_idm140352124847680" class="figure"><img class="fig-image" alt="An external file that holds a picture, illustration, etc.
Object name is nihms446094f1.jpg" title="An external file that holds a picture, illustration, etc.
Object name is nihms446094f1.jpg" src="/pmc/articles/PMC3676425/bin/nihms446094f1.jpg"></div></a><div id="largeobj_idm140352124847680" class="largeobj-link align_right" style="display: none"><a href="/pmc/articles/PMC3676425/figure/F1/" target="figure" rid-figpopup="F1" rid-ob="ob-F1"></a><a target="object" href="/pmc/articles/PMC3676425/figure/F1/?report=objectonly">Open in a separate window</a></div><div class="icnblk_cntnt" id="lgnd_F1"><div><a class="figpopup" href="/pmc/articles/PMC3676425/figure/F1/" target="figure" rid-figpopup="F1" rid-ob="ob-F1">Figure 1</a></div><!--caption a7--><div class="caption"><p id="__p5">Principal component analysis of MPN cases and WTCCC controls. The two axes represent the first two principal components. The lower right quadrant contains the cluster of individuals believed to be of northern and western European ancestry, who were selected for further analysis.</p></div></div></div><p id="P6">Given the high frequency of somatic mutations at <em>JAK2</em> in MPN<sup><a href="#R6" rid="R6" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_318236030">6</a>–<a href="#R10" rid="R10" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_318236048">10</a>,<a href="#R17" rid="R17" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_318236054">17</a></sup>, we hypothesized that rs10974944 germline variation might specifically predispose to <em>JAK2</em>-mutated MPN. We assessed rs10974944 genotype in 321 MPN cases that had been genotyped for <em>JAK2</em><sup>V617F</sup> and for <em>JAK2</em> exon 12 mutations<sup><a href="#R17" rid="R17" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_318236049">17</a></sup> and found that germline allelic variation at rs10974944 was strongly associated with <em>JAK2</em><sup>V617F</sup>-positive MPN (OR = 4.0, P = 7.7 × 10<sup>–22</sup>) and much less strongly associated with <em>JAK2</em><sup>V617F</sup>-negative MPN (OR = 1.6, P = 0.06) (<a href="/pmc/articles/PMC3676425/table/T3/" target="table" class="fig-table-link figpopup" rid-figpopup="T3" rid-ob="ob-T3" co-legend-rid=""><span>Table 3</span></a>). Allelic variation at rs10974944 was strongly associated with predisposition to polycythemia vera (OR = 4.3, P = 1.0 × 10<sup>–16</sup>) and essential thrombocythemia (OR = 2.1, P = 6.7 × 10<sup>–5</sup>) (<a href="#SD1" rid="SD1" class=" supplementary-material">Supplementary Table 2</a> online). The higher odds ratio associated with allelic variation at rs10974944 in polycythemia vera is in part due to the higher incidence of <em>JAK2</em> mutations in this condition (95%) compared to essential thrombocythemia (65%), as shown by the higher association between rs10974944 genotype and <em>JAK2</em><sup>V617F</sup>-positive essential thrombocythemia (OR = 2.8, P = 3.0 × 10<sup>–5</sup>).</p><!--table ft1--><!--table-wrap mode="anchored" t5--><div class="table-wrap table anchored whole_rhythm" id="T3"><h3>Table 3</h3><!--caption a7--><div class="caption"><p id="__p11">Germline genotype for <em>JAK2</em> SNP rs10974944 in <em>JAK2</em><sup>V617F</sup>-positive MPN cases, <em>JAK2</em><sup>V617F</sup>-negative MPN cases and WTCCC controls</p></div><div data-largeobj="" data-largeobj-link-rid="largeobj_idm140352128574032" class="xtable"><table frame="hsides" rules="groups" class="rendered small default_table"><thead><tr><th rowspan="1" colspan="1" valign="top" align="left"></th><th rowspan="1" colspan="1" valign="top" align="center"><em>JAK2</em><sup>V617F</sup>-positive<br>MPN</th><th rowspan="1" colspan="1" valign="top" align="center"><em>JAK2</em><sup>V617F</sup>-negative<br>MPN</th><th rowspan="1" colspan="1" valign="bottom" align="center">WTCCC</th></tr></thead><tbody><tr><td rowspan="1" colspan="1" valign="top" align="left">GG</td><td rowspan="1" colspan="1" valign="top" align="center">60 (24.5%)</td><td rowspan="1" colspan="1" valign="top" align="center">10 (13.5%)</td><td rowspan="1" colspan="1" valign="top" align="center">195 (6.5%)</td></tr><tr><td rowspan="1" colspan="1" valign="top" align="left">CG</td><td rowspan="1" colspan="1" valign="top" align="center">127 (51.8%)</td><td rowspan="1" colspan="1" valign="top" align="center">31 (41.9%)</td><td rowspan="1" colspan="1" valign="top" align="center">1,139 (38.0%)</td></tr><tr><td rowspan="1" colspan="1" valign="top" align="left">CC</td><td rowspan="1" colspan="1" valign="top" align="center">58 (23.7%)</td><td rowspan="1" colspan="1" valign="top" align="center">33 (44.6%)</td><td rowspan="1" colspan="1" valign="top" align="center">1,665 (55.5%)</td></tr><tr><td rowspan="1" colspan="1" valign="top" align="left">Total</td><td rowspan="1" colspan="1" valign="top" align="center">245</td><td rowspan="1" colspan="1" valign="top" align="center">74</td><td rowspan="1" colspan="1" valign="top" align="center">2,999</td></tr><tr><td colspan="4" rowspan="1" valign="bottom" align="left">
<hr></td></tr><tr><td rowspan="1" colspan="1" valign="top" align="left"><em>JAK2</em><sup>V617F</sup>-positive MPN</td><td rowspan="1" colspan="1" valign="top" align="center"><em>P</em></td><td rowspan="1" colspan="1" valign="top" align="center">OR (95% CI)</td><td rowspan="1" colspan="1" valign="top" align="center"></td></tr><tr><td colspan="4" rowspan="1" valign="bottom" align="left">
<hr></td></tr><tr><td rowspan="1" colspan="1" valign="top" align="left">GG vs. CG/CC</td><td rowspan="1" colspan="1" valign="top" align="center">8.4 × 10<sup>–24</sup></td><td rowspan="1" colspan="1" valign="top" align="center">4.7 (3.4–6.5)</td><td rowspan="1" colspan="1" valign="top" align="center"></td></tr><tr><td rowspan="1" colspan="1" valign="top" align="left">GG/CG vs. CC</td><td rowspan="1" colspan="1" valign="top" align="center">77 × 10<sup>–22</sup></td><td rowspan="1" colspan="1" valign="top" align="center">4.0 (3.0–5.5)</td><td rowspan="1" colspan="1" valign="top" align="center"></td></tr><tr><td rowspan="1" colspan="1" valign="top" align="left">GG vs. CC</td><td rowspan="1" colspan="1" valign="top" align="center">6.9 × 10<sup>–37</sup></td><td rowspan="1" colspan="1" valign="top" align="center">8.8 (6.0–13.1)</td><td rowspan="1" colspan="1" valign="top" align="center"></td></tr><tr><td rowspan="1" colspan="1" valign="top" align="left">CG vs. CC</td><td rowspan="1" colspan="1" valign="top" align="center">7.9 × 10<sup>–14</sup></td><td rowspan="1" colspan="1" valign="top" align="center">3.2 (2.3–4.4)</td><td rowspan="1" colspan="1" valign="top" align="center"></td></tr><tr><td colspan="4" rowspan="1" valign="bottom" align="left">
<hr></td></tr><tr><td rowspan="1" colspan="1" valign="top" align="left"><em>JAK2</em><sup>V617F</sup>-negative MPN</td><td rowspan="1" colspan="1" valign="top" align="center"><em>P</em></td><td rowspan="1" colspan="1" valign="top" align="center">OR (95% CI)</td><td rowspan="1" colspan="1" valign="top" align="center"></td></tr><tr><td colspan="4" rowspan="1" valign="bottom" align="left">
<hr></td></tr><tr><td rowspan="1" colspan="1" valign="top" align="left">GG vs. CG/CC</td><td rowspan="1" colspan="1" valign="top" align="center">0.017</td><td rowspan="1" colspan="1" valign="top" align="center">2.2 (1.1–4.4)</td><td rowspan="1" colspan="1" valign="top" align="center"></td></tr><tr><td rowspan="1" colspan="1" valign="top" align="left">GG/CG vs. CC</td><td rowspan="1" colspan="1" valign="top" align="center">0.06</td><td rowspan="1" colspan="1" valign="top" align="center">1.6 (1.0–2.5)</td><td rowspan="1" colspan="1" valign="top" align="center"></td></tr><tr><td rowspan="1" colspan="1" valign="top" align="left">GG vs. CC</td><td rowspan="1" colspan="1" valign="top" align="center">0.008</td><td rowspan="1" colspan="1" valign="top" align="center">2.6 (1.3–5.3)</td><td rowspan="1" colspan="1" valign="top" align="center"></td></tr><tr><td rowspan="1" colspan="1" valign="top" align="left">CG vs. CC</td><td rowspan="1" colspan="1" valign="top" align="center">0.21</td><td rowspan="1" colspan="1" valign="top" align="center">1.4 (0.8–2.3)</td><td rowspan="1" colspan="1" valign="top" align="center"></td></tr></tbody></table></div><div id="largeobj_idm140352128574032" class="largeobj-link align_right" style=""><a target="object" href="/pmc/articles/PMC3676425/table/T3/?report=objectonly">Open in a separate window</a></div></div><p id="P7">Analysis of the haplotype structure of the <em>JAK2</em> locus in CEPH founders (<a href="/pmc/articles/PMC3676425/figure/F2/" target="figure" class="fig-table-link figpopup" rid-figpopup="F2" rid-ob="ob-F2" co-legend-rid="lgnd_F2"><span>Fig. 2a</span></a>) shows that rs10974944 and <em>JAK2</em><sup>V617</sup> are contained in a common haplotype block distinct from the promoter and 5′ exons of <em>JAK2.</em> This led us to hypothesize that the G allele at rs10974944 might predispose to somatic <em>JAK2</em><sup>V617F</sup> mutations on the same strand. We investigated 42 subjects heterozygous for rs10974944 in their germline and a somatic homozygous <em>JAK2</em><sup>V617F</sup> mutant clone (<em>JAK2</em><sup>V617F</sup> allele burden &gt; 50%) and found in 38 of 42 cases somatic conversion to a homozygous GG genotype at rs10974944 (<a href="#SD1" rid="SD1" class=" supplementary-material">Supplementary Fig. 2</a> online). Using allele-specific PCR on 45 subjects heterozygous for rs10974944 in their germline and hetero-zygous for <em>JAK2</em><sup>V617F</sup> in their granulocyte DNA, we found that in 38 cases <em>JAK2<sup>V617F</sup></em> was acquired in <em>cis</em> with the G allele at rs10974944 (P = 2.8 × 10<sup>–14</sup>) (<a href="/pmc/articles/PMC3676425/figure/F2/" target="figure" class="fig-table-link figpopup" rid-figpopup="F2" rid-ob="ob-F2" co-legend-rid="lgnd_F2"><span>Fig. 2b</span></a>). These data suggest that the G allele at rs10974944 favors the in <em>cis</em> acquisition of <em>JAK2<sup>V617F</sup></em>.</p><!--fig ft0--><!--fig mode=article f1--><div class="fig iconblock whole_rhythm clearfix" id="F2" co-legend-rid="lgnd_F2"><a href="/pmc/articles/PMC3676425/figure/F2/" target="figure" rid-figpopup="F2" rid-ob="ob-F2"><!--fig/graphic|fig/alternatives/graphic mode="anchored" m1--><div data-largeobj="" data-largeobj-link-rid="largeobj_idm140352116226240" class="figure"><img class="fig-image" alt="An external file that holds a picture, illustration, etc.
Object name is nihms446094f2.jpg" title="An external file that holds a picture, illustration, etc.
Object name is nihms446094f2.jpg" src="/pmc/articles/PMC3676425/bin/nihms446094f2.jpg"></div></a><div id="largeobj_idm140352116226240" class="largeobj-link align_right" style="display: none"><a href="/pmc/articles/PMC3676425/figure/F2/" target="figure" rid-figpopup="F2" rid-ob="ob-F2"></a><a target="object" href="/pmc/articles/PMC3676425/figure/F2/?report=objectonly">Open in a separate window</a></div><div class="icnblk_cntnt" id="lgnd_F2"><div><a class="figpopup" href="/pmc/articles/PMC3676425/figure/F2/" target="figure" rid-figpopup="F2" rid-ob="ob-F2">Figure 2</a></div><!--caption a7--><div class="caption"><p id="__p6"><em>JAK2</em><sup>V617F</sup> is acquired in cis with <em>JAK2</em> SNP rs10974944. (<strong>a</strong>) Haplotype structure of the <em>JAK2</em> locus in CEPH HapMap founders, showing that rs10974944 and exon 14 of <em>JAK2</em> are in a shared haplotype approximately 3 kb apart. (<strong>b</strong>) Precise location of rs10974944 in relation to exons 12, 13 and 14, and the result of long-range PCR and clonal sequence analysis of this 3-kb fragment in a subject who was heterozygous for rs10974944 in his germline and heterozygous for <em>JAK2</em><sup>V617F</sup> in affected tissue. Analysis shows that in this subject the G allele at rs10974944 is in cis with the mutant T allele at <em>JAK2</em><sup>V617</sup>, whereas the C allele is in cis with the wild-type G allele at <em>JAK2</em><sup>V617</sup>. The G allele was found to be in cis with the mutant T allele in 38 of 45 <em>JAK2</em><sup>V617F</sup>-positive MPN cases who were heterozygous for rs10974944, suggesting that <em>JAK2</em><sup>V617F</sup> is almost always acquired in cis with the risk allele at rs10974944.</p></div></div></div><p id="P8">Given these findings, we then wished to see whether <em>JAK2</em> would be clearly detected as an MPN susceptibility locus in the context of testing SNPs genome-wide for association with MPN risk. To do so, we combined all unambiguous SNPs genotyped in MPN samples and WTCCC controls matched by principal component analysis with our data on rs10974944 and asked whether allele frequencies differed significantly between the two groups at any of the SNPs (<a href="/pmc/articles/PMC3676425/figure/F3/" target="figure" class="fig-table-link figpopup" rid-figpopup="F3" rid-ob="ob-F3" co-legend-rid="lgnd_F3"><span>Fig. 3</span></a>). Four SNPs with <em>P</em> values &lt; 10<sup>–7</sup> were significantly associated with MPN risk after correcting for residual population stratification and multiple testing. One of these four SNPs is rs10974944, further supporting the hypothesis that this represents a true MPN risk SNP and that our findings are not due to population stratification.</p><!--fig ft0--><!--fig mode=article f1--><div class="fig iconblock whole_rhythm clearfix" id="F3" co-legend-rid="lgnd_F3"><a href="/pmc/articles/PMC3676425/figure/F3/" target="figure" rid-figpopup="F3" rid-ob="ob-F3"><!--fig/graphic|fig/alternatives/graphic mode="anchored" m1--><div data-largeobj="" data-largeobj-link-rid="largeobj_idm140352127216416" class="figure"><img class="fig-image" alt="An external file that holds a picture, illustration, etc.
Object name is nihms446094f3.jpg" title="An external file that holds a picture, illustration, etc.
Object name is nihms446094f3.jpg" src="/pmc/articles/PMC3676425/bin/nihms446094f3.jpg"></div></a><div id="largeobj_idm140352127216416" class="largeobj-link align_right" style="display: none"><a href="/pmc/articles/PMC3676425/figure/F3/" target="figure" rid-figpopup="F3" rid-ob="ob-F3"></a><a target="object" href="/pmc/articles/PMC3676425/figure/F3/?report=objectonly">Open in a separate window</a></div><div class="icnblk_cntnt" id="lgnd_F3"><div><a class="figpopup" href="/pmc/articles/PMC3676425/figure/F3/" target="figure" rid-figpopup="F3" rid-ob="ob-F3">Figure 3</a></div><!--caption a7--><div class="caption"><p id="__p7">Genome-wide SNP analysis of MPN cases and WTCCC controls. The arrow marks the position of rs10974944.</p></div></div></div><p id="P9">The observation that a <em>JAK2</em> germline haplotype is markedly enriched in MPN cases compared to controls suggests that germline variation at the <em>JAK2</em> locus is an important contributor to MPN predisposition. Although genome-wide association studies have identified predisposition loci for a spectrum of human diseases, the loci identified in these studies have a modest effect on disease risk for the individual despite a larger population attributable risk. For example, a recent genome-wide association study identified six chronic lympho-cytic leukemia (CLL) predisposition loci, each of which had an odds ratio less than 1.6, but which accounted for between 12% and 39% of CLL attributable to a hereditary predisposition<sup><a href="#R18" rid="R18" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_318236052">18</a></sup>. The GG/CC genotype at <em>JAK2</em> rs10974944 contributes significantly to the excess familial risk of MPN (OR = 2.80) with a population attributable risk of 46.0%. The high population attributable risks for these predisposi-tion alleles reflect gene–gene and gene–environment interactions, and the familial relative risks due to these variants are much smaller, for example, less than 3% for CLL<sup><a href="#R19" rid="R19" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_318236039">19</a></sup>. Nonetheless, the range of genotypic relative risks reported here for <em>JAK2</em>-positive MPN are among the highest described to date using a genome-wide association approach<sup><a href="#R20" rid="R20" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_318236028">20</a></sup>.</p><p id="P10">We found that somatic <em>JAK2</em> mutations were most commonly acquired in cis with the <em>JAK2</em> predisposition haplotype, suggesting a direct interaction between haplotype-specific genetic variation in the <em>JAK2</em> locus and secondary acquisition of somatic mutations on the same strand. We did not observe genotype-specific differences in<em>JAK2</em> expression (<a href="#SD1" rid="SD1" class=" supplementary-material">Supplementary Fig. 3</a> online), nor did we observe genotype-specific nonsynonymous sequence alterations or alterations in the 3′ UTR. These data suggest that rs10974944 favors the acquisition of <em>JAK2</em> mutations in ci<em>s</em> by an unidentified mechanism. There may be haplotype-specific variation in a regulatory motif or genotype-specific splicing that increases the selective advantage of the <em>JAK2</em><sup>V617F</sup> allele when it is acquired on the predisposition haplotype. Alternatively, it is possible that genotype-specific genomic variation in the <em>JAK2</em> haplotype block increases the somatic mutation rate at this locus, as has been observed for germline variants in the <em>APC</em> gene present in the Ashkenazi Jewish population that increase the rate of somatic <em>APC</em> mutations<sup><a href="#R21" rid="R21" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_318236047">21</a></sup>. Although alternate activating <em>JAK2</em> muta-tions have been identified in acute leukemia samples and cell lines<sup><a href="#R22" rid="R22" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_318236031">22</a>,<a href="#R23" rid="R23" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_318236037">23</a></sup>, the <em>JAK2</em><sup>V617F</sup> allele overwhelmingly predominates in polycythemia vera, essential thrombocythema and primary myelofibrosis. It is thus possible that germline variation in the <em>JAK2</em> locus may be specifically associated with an increase in the rate of the guanine-to-thymidine substitution at <em>JAK2</em> codon 617.</p><p id="P11" class="p">It is likely there are additional germline loci important in MPN predisposition and pathogenesis. Our data suggests that germline variation at the <em>JAK2</em> locus has a minimal contribution to <em>JAK2</em><sup>V617F</sup>-negative MPN. Moreover, analysis of affected and unaffected members from 25 MPN kindreds did not reveal an association between <em>JAK2</em> rs10974944 genotype and MPN in these pedigrees (O.K., A.M., M.W., D.G.G. and R.L.L., unpublished data). Using genome-wide analysis of ancestry-matched cases and controls, we demonstrate that there are additional candidate loci that contribute to MPN predisposition. These data should be interpreted with the caveats that the MPN SNP data are generated from diseased tissue and that there is not complete coverage of the genome owing to strand ambiguous SNPs. In addition, this study was done on a relatively small number of samples, and it is likely that larger genome-wide association studies will identify additional germline alleles relevant to MPN pathogenesis. Taken together, these data indicate that germline variation is an important contributor to MPN pathogenesis. Moreover, this approach can be used to identify cancer predisposition loci in cancer SNP array data that is being generated by The Cancer Genome Atlas Project<sup><a href="#R24" rid="R24" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_318236043">24</a></sup> and other large-scale cancer genomics studies.</p></div><div id="S1" class="tsec sec"><div class="goto jig-ncbiinpagenav-goto-container"><a class="tgt_dark page-toc-label jig-ncbiinpagenav-goto-heading" href="#" title="Go to other sections in this page" role="button" aria-expanded="false" aria-haspopup="true">Go to:</a></div><h2 class="head no_bottom_margin ui-helper-clearfix" id="S1title">METHODS</h2><div id="S2" class="sec sec-first"><h3 id="S2title">Study samples and SNP array analysis of MPN samples</h3><p id="P12" class="p p-first-last">Samples from subjects with MPN were obtained from the Harvard MPD Study case cohort<sup><a href="#R10" rid="R10" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_318236027">10</a></sup>, all cases provided informed consent. Acute myeloid leukemia, myelodysplasia, and familial MPN samples were collected using protocols approved by the Dana Farber Cancer Institute institutional review board; all subjects provided informed consent. DNA was extracted from granulocytes and buccal swabs as previously described<sup><a href="#R10" rid="R10" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_318236040">10</a></sup>, and RNA was extracted from subject cells stored in Trizol. We chose 217 granulocyte DNA samples, including 113 samples from subjects with polycythemia vera and 68 samples from subjects with essential thrombocythemia, for SNP array analysis on the basis of clonality studies and JAK2<sup>V617F</sup> mutational burden<sup><a href="#R25" rid="R25" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_318236033">25</a></sup> in order to limit analysis to samples with &gt; 80% MPN cells. DNA samples were genotyped using Affymetrix 250K <em>StyI</em> arrays. We scanned arrays with the GeneChip Scanner 3000, and used the Affymetrix Genotyping Tools Version 2.0 to ascertain genotypes.</p></div><div id="S3" class="sec"><h3 id="S3title">Genetic analysis for modifier loci</h3><p id="P13" class="p p-first-last">Analysis of genome-wide SNP array data was done using PLINK<sup><a href="#R26" rid="R26" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_318236032">26</a></sup> unless otherwise described. To identify modifier loci, we tested all SNPs for frequency differences between 113 individuals with polycythemia vera and 68 individuals with essential thrombocythemia. Five different genetic models (genotypic, allelic, trend, dominant and recessive) were tested for each SNP, and significance at each SNP was assessed using adaptive permutation testing with a maximum of 10<sup><a href="#R8" rid="R8" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_318236051">8</a></sup> permutations. Odds ratios and confidence intervals for <a href="/pmc/articles/PMC3676425/table/T1/" target="table" class="fig-table-link figpopup" rid-figpopup="T1" rid-ob="ob-T1" co-legend-rid=""><span>Table 1</span></a> were computed based on logistic regression (–logistic option in PLINK).</p></div><div id="S4" class="sec"><h3 id="S4title">Genotyping and expression analysis</h3><p id="P14" class="p p-first-last">Granulocyte and buccal DNA samples were genotyped using TaqMan SNP genotyping assays for rs10974944 and rs12500918 (Applied Biosystems) assays. DNA samples from CEU HapMap founders were used as controls. We measured expression of <em>JAK2</em> and <em>HPRT1</em> using TaqMan Gene Expression Assays (Applied Biosystems).</p></div><div id="S5" class="sec"><h3 id="S5title"><em>JAK2</em> rs10974944 mutation clonal analysis</h3><p id="P15" class="p p-first-last">A 3-kb PCR product containing rs10974944 and exon 14 of <em>JAK2,</em> where 1849G &gt; T (V617F) resides, was amplified from <em>JAK2</em><sup>V617F</sup> -positive subjects heterozygous for rs10974944 in the germline using allele-specific forward primers and a common reverse primer followed by sequencing the 1849G &gt; T site with the reverse primer (<a href="#SD1" rid="SD1" class=" supplementary-material">Supplementary Table 3</a> online). To validate the allele-specific PCR assay we cloned the 3-kb fragment from 11 cases using the TOPO TA Cloning Kit (Invitrogen), and sequenced sufficient individual colonies from each subject to ascertain which genotype at rs10974944 was in <em>cis</em> with the 1849G &gt; T (V617F) allele in granulocyte DNA from each informative subject.</p></div><div id="S6" class="sec"><h3 id="S6title">Principal component analysis of MPN cases and controls</h3><p id="P16" class="p p-first">For principal component analysis we used genome-wide data from the 217 MPN cases and from 3,000 controls from the Wellcome Trust Case Control consortium<sup><a href="#R27" rid="R27" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_318236024">27</a></sup>, which were genotyped with the Affymetrix GeneChip 500k Mapping Array Set, of which the 250 K Sty chip is a subset. Before analysis, we carried out quality control filtering of both samples and SNP separately for cases and controls and then merged the dataset using the common set of SNPs present in the two cohorts. To do so, we first filtered out the ambiguous SNPs (A/Tor G/C alleles) to ensure we unambiguously know strand when we merge the two datasets. We removed 35,218 ambiguous markers (out of 231,786) from the MPN genotype dataset and 77,934 ambiguous markers (out of 486,661) from the WTCCC control cohort. The quality control filters and quality assessment removed subjects with low genotype completion rates (&lt; 90%). Further data cleaning of the autosomal SNPs typed in both datasets retained SNPs that have a minor allele frequency (MAF) &gt; 5%, a rate of missing genotype &lt; 1%, and are in Hardy-Weinberg equilibrium in the WTCCC controls (exact test <em>P &gt;</em> 10<sup>–7</sup> ). In total, 62,775 markers were identified for analysis and used in the merged case and control dataset.</p><p id="P17">To investigate potential population stratification biases that could be introduced by the shared controls, we carried out principal component analysis using EIGENSTRAT<sup><a href="#R28" rid="R28" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_318236038">28</a></sup> . To reduce the linkage disequilibrium between markers, we first used PLINK to filter markers such that all remaining markers are in low LD (r<sup>2</sup> &lt; 0.1, calculated in sliding windows 50 SNPs wide, shifted and recalculated every 5 SNPs). We applied the EIGENSTRAT program with default parameters and no outlier removal to infer axes of variation in the combined dataset. The case and controls that clustered together on the eigenvector plot (with the first two axes of variation) were used for the association analysis.</p><p id="P18" class="p p-last">The main SNP of interest in <em>JAK2,</em> rs10974944, has G and C alleles and was therefore eliminated by our filtering for ambiguous SNPs. To see at what rank it would appear in a GWAS for MPN risk alleles, we included it in our genome-wide association analysis. Specifically, we included the germline genotypes generated using TaqMan for the cases with the genotypes provided by the WTCCC data for the controls. A test of allelic association was done using –assoc in PLINK.</p></div><div id="S7" class="sec sec-last"><h3 id="S7title">Statistical analysis</h3><p id="P19" class="p p-first-last">The frequencies of the genotypes between cases and controls were compared using Pearson’s χ<sup><a href="#R2" rid="R2" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_318236041">2</a></sup> test and, when required, Fisher’s exact test. The ANOVA test was used for comparison of JAK2<sup>V617F</sup> allele burden between different genotypes. SPSS version 16.0 for Windows (SPSS) was used for all statistical tests.</p></div></div><div id="S8" class="tsec sec"><a id="supplementary-material-sec"></a><div class="goto jig-ncbiinpagenav-goto-container"><a class="tgt_dark page-toc-label jig-ncbiinpagenav-goto-heading" href="#" title="Go to other sections in this page" role="button" aria-expanded="false" aria-haspopup="true">Go to:</a></div><h2 class="head no_bottom_margin ui-helper-clearfix" id="S8title">Supplementary Material</h2><!--/article/body/sec/--><div class="sec suppmat" id="SD1"><h4>Supplements</h4><div class="sup-box half_rhythm" id="d36e801"><a href="/pmc/articles/PMC3676425/bin/NIHMS446094-supplement-Supplements.pdf" data-ga-action="click_feat_suppl">Click here to view.</a><sup>(336K, pdf)</sup></div></div></div><div id="S9" class="tsec sec"><div class="goto jig-ncbiinpagenav-goto-container"><a class="tgt_dark page-toc-label jig-ncbiinpagenav-goto-heading" href="#" title="Go to other sections in this page" role="button" aria-expanded="false" aria-haspopup="true">Go to:</a></div><h2 class="head no_bottom_margin ui-helper-clearfix" id="S9title">Acknowledgments</h2><div class="sec"><p id="__p2">We would like to acknowledge the subjects who have contributed to our understanding of these disorders. We thank S. Thomas, I. Dolgalev and T. Landers for assistance with high-throughput resequencing, A. Viale for assistance with JAK2 expression analysis, and T. Kirchhoff for advice and suggestions. This study makes use of data generated by the Wellcome Trust Case-Control Consortium; a full list of the investigators who contributed to the generation of the data are available from <a href="http://www.wtccc.org.uk" data-ga-action="click_feat_suppl" ref="reftype=extlink&amp;article-id=3676425&amp;issue-id=223738&amp;journal-id=319&amp;FROM=Article%7CBody&amp;TO=External%7CLink%7CURI" target="_blank">http://www.wtccc.org.uk</a> and funding was provided by the Wellcome Trust under award 076113. This work was supported by grants from the National Institutes of Health, the Starr Cancer Consortium, the Myeloproliferative Disorders Foundation, the Howard Hughes Medical Institute, the Doris Duke Charitable Foundation and the Kristen Amico Sesselman Leukemia Research Fund. O.K. is supported by a grant from the Academy of Finland. D.G.G. is an Investigator of the Howard Hughes Medical Institute and is a Doris Duke Charitable Foundation Distinguished Clinical Scientist. Work in the laboratory of R.J.K. is supported by Memorial Sloan Kettering Cancer Center through US National Institutes of Health grant P30 CA008748. R.L.L. is an Early Career Award recipient of the Howard Hughes Medical Institute and a Clinical Scientist Development Award recipient of the Doris Duke Charitable Foundation and is the Geoffrey Beene Junior Chair at Memorial Sloan Kettering Cancer Center.</p></div></div><div id="idm140352113395712" class="tsec sec"><div class="goto jig-ncbiinpagenav-goto-container"><a class="tgt_dark page-toc-label jig-ncbiinpagenav-goto-heading" href="#" title="Go to other sections in this page" role="button" aria-expanded="false" aria-haspopup="true">Go to:</a></div><h2 class="head no_bottom_margin ui-helper-clearfix" id="idm140352113395712title">Footnotes</h2><!--back/fn-group--><div class="fm-sec half_rhythm small"><div><p id="__p3" class="p p-first">AUTHOR CONTRIBUTIONS</p>The study was designed by O.K., S. Mukherjee, R.J.K. and R.L.L. with advice from K.O. SNP arrays were performed and analyzed by A.B., B.L.E. and R.L.L, and analysis of SNP array data for modifier and predisposition loci was performed by S. Mukherjee and R.J.K. Genotyping, sequence analysis and realtime PCR assays were performed by O.K., A.M.S., S. Marubayashi, A.H. and R.L.L. Principal component analysis was done by S. Mukherjee and R.J.K. Identification of subjects, sample collection and phenotypic assessment were done by M.W., A.M., G.G.-M., H.K., R.M.S, D.G.G. and R.L.L. The paper was written by O.K., S. Mukherjee, K.O., D.G.G., R.J.K. and R.L.L. All authors discussed the results and commented on the manuscript.</div></div></div><div id="idm140352125389552" class="tsec sec"><div class="goto jig-ncbiinpagenav-goto-container"><a class="tgt_dark page-toc-label jig-ncbiinpagenav-goto-heading" href="#" title="Go to other sections in this page" role="button" aria-expanded="false" aria-haspopup="true">Go to:</a></div><h2 class="head no_bottom_margin ui-helper-clearfix" id="idm140352125389552title">References</h2><div class="ref-list-sec sec" id="reference-list"><div class="ref-cit-blk half_rhythm" id="R1">1. <span class="element-citation">Adamson JW, Fialkow PJ, Murphy S, Prchal JF, Steinmann L. Polycythemia vera: stem-cell and probable clonal origin of the disease. <span><span class="ref-journal">N Engl J Med. </span>1976;<span class="ref-vol">295</span>:913–916.</span> [<a href="/pubmed/967201" target="pmc_ext" ref="reftype=pubmed&amp;article-id=3676425&amp;issue-id=223738&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=N+Engl+J+Med&amp;title=Polycythemia+vera:+stem-cell+and+probable+clonal+origin+of+the+disease&amp;author=JW+Adamson&amp;author=PJ+Fialkow&amp;author=S+Murphy&amp;author=JF+Prchal&amp;author=L+Steinmann&amp;volume=295&amp;publication_year=1976&amp;pages=913-916&amp;pmid=967201&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=3676425&amp;issue-id=223738&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" aria-expanded="false" aria-haspopup="true">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="R2">2. <span class="element-citation">Gilliland DG, Blanchard KL, Levy J, Perrin S, Bunn HF. Clonality in myeloproliferative disorders: analysis by means of the polymerase chain reaction. <span><span class="ref-journal">Proc Natl Acad Sci USA. </span>1991;<span class="ref-vol">88</span>:6848–6852.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC52186/">PMC free article</a>]</span> [<a href="/pubmed/1862109" target="pmc_ext" ref="reftype=pubmed&amp;article-id=3676425&amp;issue-id=223738&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Proc+Natl+Acad+Sci+USA&amp;title=Clonality+in+myeloproliferative+disorders:+analysis+by+means+of+the+polymerase+chain+reaction&amp;author=DG+Gilliland&amp;author=KL+Blanchard&amp;author=J+Levy&amp;author=S+Perrin&amp;author=HF+Bunn&amp;volume=88&amp;publication_year=1991&amp;pages=6848-6852&amp;pmid=1862109&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=3676425&amp;issue-id=223738&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" aria-expanded="false" aria-haspopup="true">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="R3">3. <span class="element-citation">El Kassar N, Hetet G, Li Y, Briere J, Grandchamp B. Clonal analysis of haemopoietic cells in essential thrombocythaemia. <span><span class="ref-journal">Br J Haem. </span>1995;<span class="ref-vol">90</span>:131–137.</span> [<a href="/pubmed/7786775" target="pmc_ext" ref="reftype=pubmed&amp;article-id=3676425&amp;issue-id=223738&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Br+J+Haem&amp;title=Clonal+analysis+of+haemopoietic+cells+in+essential+thrombocythaemia&amp;author=N+El+Kassar&amp;author=G+Hetet&amp;author=Y+Li&amp;author=J+Briere&amp;author=B+Grandchamp&amp;volume=90&amp;publication_year=1995&amp;pages=131-137&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=3676425&amp;issue-id=223738&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" aria-expanded="false" aria-haspopup="true">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="R4">4. <span class="element-citation">Tsukamoto N, et al.  Clonality in chronic myeloproliferative disorders defined by X-chromosome linked probes: demonstration of heterogeneity in lineage involvement. <span><span class="ref-journal">Br J Haematol. </span>1994;<span class="ref-vol">86</span>:253–258.</span> [<a href="/pubmed/7911034" target="pmc_ext" ref="reftype=pubmed&amp;article-id=3676425&amp;issue-id=223738&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Br+J+Haematol&amp;title=Clonality+in+chronic+myeloproliferative+disorders+defined+by+X-chromosome+linked+probes:+demonstration+of+heterogeneity+in+lineage+involvement&amp;author=N+Tsukamoto&amp;volume=86&amp;publication_year=1994&amp;pages=253-258&amp;pmid=7911034&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=3676425&amp;issue-id=223738&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" aria-expanded="false" aria-haspopup="true">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="R5">5. <span class="element-citation">Jamieson CH, et al.  The JAK2 V617F mutation occurs in hematopoietic stem cells in polycythemia vera and predisposes toward erythroid differentiation. <span><span class="ref-journal">Proc Natl Acad Sci USA. </span>2006;<span class="ref-vol">103</span>:6224–6229.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC1434515/">PMC free article</a>]</span> [<a href="/pubmed/16603627" target="pmc_ext" ref="reftype=pubmed&amp;article-id=3676425&amp;issue-id=223738&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Proc+Natl+Acad+Sci+USA&amp;title=The+JAK2+V617F+mutation+occurs+in+hematopoietic+stem+cells+in+polycythemia+vera+and+predisposes+toward+erythroid+differentiation&amp;author=CH+Jamieson&amp;volume=103&amp;publication_year=2006&amp;pages=6224-6229&amp;pmid=16603627&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=3676425&amp;issue-id=223738&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" aria-expanded="false" aria-haspopup="true">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="R6">6. <span class="element-citation">James C, et al.  A unique clonal JAK2 mutation leading to constitutive signalling causes polycythaemia vera. <span><span class="ref-journal">Nature. </span>2005;<span class="ref-vol">434</span>:1144–1148.</span> [<a href="/pubmed/15793561" target="pmc_ext" ref="reftype=pubmed&amp;article-id=3676425&amp;issue-id=223738&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Nature&amp;title=A+unique+clonal+JAK2+mutation+leading+to+constitutive+signalling+causes+polycythaemia+vera&amp;author=C+James&amp;volume=434&amp;publication_year=2005&amp;pages=1144-1148&amp;pmid=15793561&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=3676425&amp;issue-id=223738&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" aria-expanded="false" aria-haspopup="true">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="R7">7. <span class="element-citation">Baxter EJ, et al.  Acquired mutation of the tyrosine kinase JAK2 in human myeloproliferative disorders. <span><span class="ref-journal">Lancet. </span>2005;<span class="ref-vol">365</span>:1054–1061.</span> [<a href="/pubmed/15781101" target="pmc_ext" ref="reftype=pubmed&amp;article-id=3676425&amp;issue-id=223738&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Lancet&amp;title=Acquired+mutation+of+the+tyrosine+kinase+JAK2+in+human+myeloproliferative+disorders&amp;author=EJ+Baxter&amp;volume=365&amp;publication_year=2005&amp;pages=1054-1061&amp;pmid=15781101&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=3676425&amp;issue-id=223738&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" aria-expanded="false" aria-haspopup="true">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="R8">8. <span class="element-citation">Kralovics R, et al.  A gain-of-function mutation of JAK2 in myeloproliferative disorders. <span><span class="ref-journal">N Engl J Med. </span>2005;<span class="ref-vol">352</span>:1779–1790.</span> [<a href="/pubmed/15858187" target="pmc_ext" ref="reftype=pubmed&amp;article-id=3676425&amp;issue-id=223738&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=N+Engl+J+Med&amp;title=A+gain-of-function+mutation+of+JAK2+in+myeloproliferative+disorders&amp;author=R+Kralovics&amp;volume=352&amp;publication_year=2005&amp;pages=1779-1790&amp;pmid=15858187&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=3676425&amp;issue-id=223738&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" aria-expanded="false" aria-haspopup="true">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="R9">9. <span class="element-citation">Zhao R, et al.  Identification of an acquired JAK2 mutation in polycythemia vera. <span><span class="ref-journal">J Biol Chem. </span>2005;<span class="ref-vol">280</span>:22788–22792.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC1201515/">PMC free article</a>]</span> [<a href="/pubmed/15863514" target="pmc_ext" ref="reftype=pubmed&amp;article-id=3676425&amp;issue-id=223738&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=J+Biol+Chem&amp;title=Identification+of+an+acquired+JAK2+mutation+in+polycythemia+vera&amp;author=R+Zhao&amp;volume=280&amp;publication_year=2005&amp;pages=22788-22792&amp;pmid=15863514&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=3676425&amp;issue-id=223738&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" aria-expanded="false" aria-haspopup="true">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="R10">10. <span class="element-citation">Levine RL, et al.  Activating mutation in the tyrosine kinase JAK2 in polycythemia vera, essential thrombocythemia, and myeloid metaplasia with myelofibrosis. <span><span class="ref-journal">Cancer Cell. </span>2005;<span class="ref-vol">7</span>:387–397.</span> [<a href="/pubmed/15837627" target="pmc_ext" ref="reftype=pubmed&amp;article-id=3676425&amp;issue-id=223738&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Cancer+Cell&amp;title=Activating+mutation+in+the+tyrosine+kinase+JAK2+in+polycythemia+vera,+essential+thrombocythemia,+and+myeloid+metaplasia+with+myelofibrosis&amp;author=RL+Levine&amp;volume=7&amp;publication_year=2005&amp;pages=387-397&amp;pmid=15837627&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=3676425&amp;issue-id=223738&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" aria-expanded="false" aria-haspopup="true">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="R11">11. <span class="element-citation">Landgren O, et al.  Increased risks of polycythemia vera, essential thrombocythemia, and myelofibrosis among 24577 first-degree relatives of 11039 patients with myelo-proliferative neoplasms in Sweden. <span><span class="ref-journal">Blood. </span>2008;<span class="ref-vol">112</span>:2199–2204.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC2532797/">PMC free article</a>]</span> [<a href="/pubmed/18451307" target="pmc_ext" ref="reftype=pubmed&amp;article-id=3676425&amp;issue-id=223738&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Blood&amp;title=Increased+risks+of+polycythemia+vera,+essential+thrombocythemia,+and+myelofibrosis+among+24577+first-degree+relatives+of+11039+patients+with+myelo-proliferative+neoplasms+in+Sweden&amp;author=O+Landgren&amp;volume=112&amp;publication_year=2008&amp;pages=2199-2204&amp;pmid=18451307&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=3676425&amp;issue-id=223738&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" aria-expanded="false" aria-haspopup="true">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="R12">12. <span class="element-citation">Pardanani A, Fridley BL, Lasho TL, Gilliland DG, Tefferi A. Host genetic variation contributes to phenotypic diversity in myeloproliferative disorders. <span><span class="ref-journal">Blood. </span>2008;<span class="ref-vol">111</span>:2785–2789.</span> [<a href="/pubmed/18006699" target="pmc_ext" ref="reftype=pubmed&amp;article-id=3676425&amp;issue-id=223738&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Blood&amp;title=Host+genetic+variation+contributes+to+phenotypic+diversity+in+myeloproliferative+disorders&amp;author=A+Pardanani&amp;author=BL+Fridley&amp;author=TL+Lasho&amp;author=DG+Gilliland&amp;author=A+Tefferi&amp;volume=111&amp;publication_year=2008&amp;pages=2785-2789&amp;pmid=18006699&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=3676425&amp;issue-id=223738&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" aria-expanded="false" aria-haspopup="true">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="R13">13. <span class="element-citation">Cario H, Goerttler PS, Steimle C, Levine RL, Pahl HL. The JAK2V617F mutation is acquired secondary to the predisposing alteration in familial polycythaemia vera. <span><span class="ref-journal">Br J Haematol. </span>2005;<span class="ref-vol">130</span>:800–801.</span> [<a href="/pubmed/16115144" target="pmc_ext" ref="reftype=pubmed&amp;article-id=3676425&amp;issue-id=223738&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Br+J+Haematol&amp;title=The+JAK2V617F+mutation+is+acquired+secondary+to+the+predisposing+alteration+in+familial+polycythaemia+vera&amp;author=H+Cario&amp;author=PS+Goerttler&amp;author=C+Steimle&amp;author=RL+Levine&amp;author=HL+Pahl&amp;volume=130&amp;publication_year=2005&amp;pages=800-801&amp;pmid=16115144&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=3676425&amp;issue-id=223738&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" aria-expanded="false" aria-haspopup="true">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="R14">14. <span class="element-citation">Bellanne-Chantelot C, et al.  Genetic and clinical implications of the Val617Phe JAK2 mutation in 72 families with myeloproliferative disorders. <span><span class="ref-journal">Blood. </span>2006;<span class="ref-vol">108</span>:346–352.</span> [<a href="/pubmed/16537803" target="pmc_ext" ref="reftype=pubmed&amp;article-id=3676425&amp;issue-id=223738&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Blood&amp;title=Genetic+and+clinical+implications+of+the+Val617Phe+JAK2+mutation+in+72+families+with+myeloproliferative+disorders&amp;author=C+Bellanne-Chantelot&amp;volume=108&amp;publication_year=2006&amp;pages=346-352&amp;pmid=16537803&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=3676425&amp;issue-id=223738&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" aria-expanded="false" aria-haspopup="true">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="R15">15. <span class="element-citation">Pietra D, et al.  Somatic mutations of JAK2 exon 12 in patients with JAK2 (V617F)-negative myeloproliferative disorders. <span><span class="ref-journal">Blood. </span>2008;<span class="ref-vol">111</span>:1686–1689.</span> [<a href="/pubmed/17984312" target="pmc_ext" ref="reftype=pubmed&amp;article-id=3676425&amp;issue-id=223738&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Blood&amp;title=Somatic+mutations+of+JAK2+exon+12+in+patients+with+JAK2+(V617F)-negative+myeloproliferative+disorders&amp;author=D+Pietra&amp;volume=111&amp;publication_year=2008&amp;pages=1686-1689&amp;pmid=17984312&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=3676425&amp;issue-id=223738&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" aria-expanded="false" aria-haspopup="true">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="R16">16. <span class="element-citation">Scott LM, Scott MA, Campbell PJ, Green AR. Progenitors homozygous for the V617F mutation occur in most patients with polycythemia vera, but not essential thrombocythemia. <span><span class="ref-journal">Blood. </span>2006;<span class="ref-vol">108</span>:2435–2437.</span> [<a href="/pubmed/16772604" target="pmc_ext" ref="reftype=pubmed&amp;article-id=3676425&amp;issue-id=223738&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Blood&amp;title=Progenitors+homozygous+for+the+V617F+mutation+occur+in+most+patients+with+polycythemia+vera,+but+not+essential+thrombocythemia&amp;author=LM+Scott&amp;author=MA+Scott&amp;author=PJ+Campbell&amp;author=AR+Green&amp;volume=108&amp;publication_year=2006&amp;pages=2435-2437&amp;pmid=16772604&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=3676425&amp;issue-id=223738&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" aria-expanded="false" aria-haspopup="true">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="R17">17. <span class="element-citation">Scott LM, et al.  JAK2 exon 12 mutations in polycythemia vera and idiopathic erythrocytosis. <span><span class="ref-journal">N Engl J Med. </span>2007;<span class="ref-vol">356</span>:459–468.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC2873834/">PMC free article</a>]</span> [<a href="/pubmed/17267906" target="pmc_ext" ref="reftype=pubmed&amp;article-id=3676425&amp;issue-id=223738&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=N+Engl+J+Med&amp;title=JAK2+exon+12+mutations+in+polycythemia+vera+and+idiopathic+erythrocytosis&amp;author=LM+Scott&amp;volume=356&amp;publication_year=2007&amp;pages=459-468&amp;pmid=17267906&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=3676425&amp;issue-id=223738&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" aria-expanded="false" aria-haspopup="true">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="R18">18. <span class="element-citation">Di Bernardo MC, et al.  A genome-wide association study identifies six susceptibility loci for chronic lymphocytic leukemia. <span><span class="ref-journal">Nat Genet. </span>2008;<span class="ref-vol">40</span>:1204–1210.</span> [<a href="/pubmed/18758461" target="pmc_ext" ref="reftype=pubmed&amp;article-id=3676425&amp;issue-id=223738&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Nat+Genet&amp;title=A+genome-wide+association+study+identifies+six+susceptibility+loci+for+chronic+lymphocytic+leukemia&amp;author=MC+Di+Bernardo&amp;volume=40&amp;publication_year=2008&amp;pages=1204-1210&amp;pmid=18758461&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=3676425&amp;issue-id=223738&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" aria-expanded="false" aria-haspopup="true">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="R19">19. <span class="element-citation">Hemminki K, Forsti A, Bermejo JL. The ’common disease-common variant’ hypothesis and familial risks. <span><span class="ref-journal">PLoS ONE. </span>2008;<span class="ref-vol">3</span>:e2504.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC2423486/">PMC free article</a>]</span> [<a href="/pubmed/18560565" target="pmc_ext" ref="reftype=pubmed&amp;article-id=3676425&amp;issue-id=223738&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=PLoS+ONE&amp;title=The+’common+disease-common+variant’+hypothesis+and+familial+risks&amp;author=K+Hemminki&amp;author=A+Forsti&amp;author=JL+Bermejo&amp;volume=3&amp;publication_year=2008&amp;pages=e2504&amp;pmid=18560565&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=3676425&amp;issue-id=223738&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" aria-expanded="false" aria-haspopup="true">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="R20">20. <span class="element-citation">Hemminki K, Forsti A, Lorenzo Bermejo J. New cancer susceptibility loci: population and familial risks. <span><span class="ref-journal">Int J Cancer. </span>2008;<span class="ref-vol">123</span>:1726–1729.</span> [<a href="/pubmed/18623115" target="pmc_ext" ref="reftype=pubmed&amp;article-id=3676425&amp;issue-id=223738&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Int+J+Cancer&amp;title=New+cancer+susceptibility+loci:+population+and+familial+risks&amp;author=K+Hemminki&amp;author=A+Forsti&amp;author=J+Lorenzo+Bermejo&amp;volume=123&amp;publication_year=2008&amp;pages=1726-1729&amp;pmid=18623115&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=3676425&amp;issue-id=223738&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" aria-expanded="false" aria-haspopup="true">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="R21">21. <span class="element-citation">Laken SJ, et al.  Familial colorectal cancer in Ashkenazim due to a hypermutable tract in APC. <span><span class="ref-journal">Nat Genet. </span>1997;<span class="ref-vol">17</span>:79–83.</span> [<a href="/pubmed/9288102" target="pmc_ext" ref="reftype=pubmed&amp;article-id=3676425&amp;issue-id=223738&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Nat+Genet&amp;title=Familial+colorectal+cancer+in+Ashkenazim+due+to+a+hypermutable+tract+in+APC&amp;author=SJ+Laken&amp;volume=17&amp;publication_year=1997&amp;pages=79-83&amp;pmid=9288102&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=3676425&amp;issue-id=223738&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" aria-expanded="false" aria-haspopup="true">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="R22">22. <span class="element-citation">Bercovich D, et al.  Mutations of JAK2 in acute lymphoblastic leukaemias associated with Down’s syndrome. <span><span class="ref-journal">Lancet. </span>2008;<span class="ref-vol">372</span>:1484–1492.</span> [<a href="/pubmed/18805579" target="pmc_ext" ref="reftype=pubmed&amp;article-id=3676425&amp;issue-id=223738&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Lancet&amp;title=Mutations+of+JAK2+in+acute+lymphoblastic+leukaemias+associated+with+Down’s+syndrome&amp;author=D+Bercovich&amp;volume=372&amp;publication_year=2008&amp;pages=1484-1492&amp;pmid=18805579&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=3676425&amp;issue-id=223738&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" aria-expanded="false" aria-haspopup="true">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="R23">23. <span class="element-citation">Mercher T, et al.  JAK2T875N is a novel activating mutation that results in myelo-proliferative disease with features of megakaryoblastic leukemia in a murine bone marrow transplantation model. <span><span class="ref-journal">Blood. </span>2006;<span class="ref-vol">108</span>:2770–2779.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC1895587/">PMC free article</a>]</span> [<a href="/pubmed/16804112" target="pmc_ext" ref="reftype=pubmed&amp;article-id=3676425&amp;issue-id=223738&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Blood&amp;title=JAK2T875N+is+a+novel+activating+mutation+that+results+in+myelo-proliferative+disease+with+features+of+megakaryoblastic+leukemia+in+a+murine+bone+marrow+transplantation+model&amp;author=T+Mercher&amp;volume=108&amp;publication_year=2006&amp;pages=2770-2779&amp;pmid=16804112&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=3676425&amp;issue-id=223738&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" aria-expanded="false" aria-haspopup="true">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="R24">24. <span class="element-citation">The Cancer Genome Atlas Research Network. Comprehensive genomic characterization defines human glioblastoma genes and core pathways. <span><span class="ref-journal">Nature. </span>2008;<span class="ref-vol">455</span>:1061–1068.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC2671642/">PMC free article</a>]</span> [<a href="/pubmed/18772890" target="pmc_ext" ref="reftype=pubmed&amp;article-id=3676425&amp;issue-id=223738&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Nature&amp;title=Comprehensive+genomic+characterization+defines+human+glioblastoma+genes+and+core+pathways&amp;volume=455&amp;publication_year=2008&amp;pages=1061-1068&amp;pmid=18772890&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=3676425&amp;issue-id=223738&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" aria-expanded="false" aria-haspopup="true">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="R25">25. <span class="element-citation">Levine RL, et al.  X-inactivation-based clonality analysis and quantitative JAK2V617F assessment reveal a strong association between clonality and JAK2V617F in PV but not ET/MMM, and identifies a subset of JAK2V617F-negative ET and MMM patients with clonal hematopoiesis. <span><span class="ref-journal">Blood. </span>2006;<span class="ref-vol">107</span>:4139–4141.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC1895292/">PMC free article</a>]</span> [<a href="/pubmed/16434490" target="pmc_ext" ref="reftype=pubmed&amp;article-id=3676425&amp;issue-id=223738&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Blood&amp;title=X-inactivation-based+clonality+analysis+and+quantitative+JAK2V617F+assessment+reveal+a+strong+association+between+clonality+and+JAK2V617F+in+PV+but+not+ET/MMM,+and+identifies+a+subset+of+JAK2V617F-negative+ET+and+MMM+patients+with+clonal+hematopoiesis&amp;author=RL+Levine&amp;volume=107&amp;publication_year=2006&amp;pages=4139-4141&amp;pmid=16434490&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=3676425&amp;issue-id=223738&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" aria-expanded="false" aria-haspopup="true">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="R26">26. <span class="element-citation">Purcell S, et al.  PLINK: a tool set for whole-genome association and population-based linkage analyses. <span><span class="ref-journal">Am J Hum Genet. </span>2007;<span class="ref-vol">81</span>:559–575.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC1950838/">PMC free article</a>]</span> [<a href="/pubmed/17701901" target="pmc_ext" ref="reftype=pubmed&amp;article-id=3676425&amp;issue-id=223738&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Am+J+Hum+Genet&amp;title=PLINK:+a+tool+set+for+whole-genome+association+and+population-based+linkage+analyses&amp;author=S+Purcell&amp;volume=81&amp;publication_year=2007&amp;pages=559-575&amp;pmid=17701901&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=3676425&amp;issue-id=223738&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" aria-expanded="false" aria-haspopup="true">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="R27">27. <span class="element-citation">The Wellcome Trust Case Control Consortium. Genome-wide association study of 14,000 cases of seven common diseases and 3,000 shared controls. <span><span class="ref-journal">Nature. </span>2007;<span class="ref-vol">447</span>:661–678.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC2719288/">PMC free article</a>]</span> [<a href="/pubmed/17554300" target="pmc_ext" ref="reftype=pubmed&amp;article-id=3676425&amp;issue-id=223738&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Nature&amp;title=Genome-wide+association+study+of+14,000+cases+of+seven+common+diseases+and+3,000+shared+controls&amp;volume=447&amp;publication_year=2007&amp;pages=661-678&amp;pmid=17554300&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=3676425&amp;issue-id=223738&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" aria-expanded="false" aria-haspopup="true">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="R28">28. <span class="element-citation">Price AL, et al.  Principal components analysis corrects for stratification in genome-wide association studies. <span><span class="ref-journal">Nat Genet. </span>2006;<span class="ref-vol">38</span>:904–909.</span> [<a href="/pubmed/16862161" target="pmc_ext" ref="reftype=pubmed&amp;article-id=3676425&amp;issue-id=223738&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Nat+Genet&amp;title=Principal+components+analysis+corrects+for+stratification+in+genome-wide+association+studies&amp;author=AL+Price&amp;volume=38&amp;publication_year=2006&amp;pages=904-909&amp;pmid=16862161&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=3676425&amp;issue-id=223738&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" aria-expanded="false" aria-haspopup="true">Google Scholar</a>]</span></span></div></div></div><div style="display: none; width: 200px; top: -100px; left: -100px;" aria-live="assertive" aria-hidden="true" class="ui-helper-reset ui-ncbipopper-wrapper ui-ncbilinksmenu"><ul id="ui-ncbiinpagenav-2"><li><a href="#ui-ncbiinpagenav-heading-3">Associated Data</a></li><li><a href="#idm140352125432944title">Abstract</a></li><li><a href="#S1title">METHODS</a></li><li><a href="#S8title">Supplementary Material</a></li><li><a href="#S9title">Acknowledgments</a></li><li><a href="#idm140352113395712title">Footnotes</a></li><li><a href="#idm140352125389552title">References</a></li></ul></div></div><!--post-content--></div>
            
            
        
            
        </div>
        <!-- Book content -->
    </div>
    
    <div id="rightcolumn" class="four_col col last">
        <!-- Custom content above discovery portlets -->
        <div class="col6">
            
        </div>
        
        <div xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance"><div class="format-menu"><h2>Formats:</h2><ul><li class="selected">Article</li> | <li><a href="/pmc/articles/PMC3676425/?report=reader">PubReader</a></li> | <li class="epub-link"><a href="/pmc/articles/PMC3676425/epub/">ePub (beta)</a></li> | <li><a href="/pmc/articles/PMC3676425/pdf/nihms446094.pdf">PDF (515K)</a></li> | <li><a href="#" data-citationid="PMC3676425" class="citationexporter ctxp" role="button" aria-expanded="false" aria-haspopup="true">Citation</a></li></ul></div></div><div xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="share-buttons"><h2>Share</h2><ul><li class="facebook"><a href="https://www.facebook.com/sharer/sharer.php?u=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC3676425%2F" role="button" aria-expanded="false" aria-haspopup="true" target="_blank"><img src="//static.pubmed.gov/portal/portal3rc.fcgi/4160049/img/4047626" alt="Share on Facebook">
                             Facebook
                        </a></li><li class="twitter"><a href="https://twitter.com/intent/tweet?url=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC3676425%2F&amp;text=A%20germline%20JAK2%20SNP%20is%20associated%20with%20predisposition%20to%20the%20development%20of%20JAK2V617F-positive%20myeloproliferative%20neoplasms" role="button" aria-expanded="false" aria-haspopup="true" target="_blank"><img src="//static.pubmed.gov/portal/portal3rc.fcgi/4160049/img/4047627" alt="Share on Twitter">
                             Twitter
                        </a></li><li class="gplus"><a href="https://plus.google.com/share?url=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC3676425%2F" role="button" aria-expanded="false" aria-haspopup="true" target="_blank"><img src="//static.pubmed.gov/portal/portal3rc.fcgi/4160049/img/4047628" alt="Share on Google Plus">
                             Google+
                        </a></li></ul></div>
        
        <div id="ajax-portlets" data-pmid="19287384" data-aiid="3676425" data-aid="3676425" data-iid="223738" data-domainid="319" data-domain="nihpa" data-accid="PMC3676425" data-md5="42eaefd0deb02fbe2413d7f16045b8c3"><img src="/portal/portal3rc.fcgi/4018218/img/3631476" alt="Loading..." align="absmiddle"> Loading portlets...</div>
                
        <!-- Custom content below discovery portlets -->
        <div class="col7">
            
        </div>
    </div>
</div>

<!-- Custom content after all -->
<div class="col8">
    
</div>
<div class="col9">
    
</div>

<script src="/corehtml/pmc/js/jquery.scrollTo-1.4.2.js"></script>
<script>
    (function($){
        $('.skiplink').each(function(i, item){
            var href = $($(item).attr('href'));
            href.attr('tabindex', '-1').addClass('skiptarget'); // ensure the target can receive focus
            $(item).on('click', function(event){
                event.preventDefault();
                $.scrollTo(href, 0, {
                    onAfter: function(){
                        href.focus();
                    }
                });
            });
        });
    })(jQuery);
</script>



<div id="body-link-poppers"></div>
                        </div>
                        <div class="bottom">
                            
                            <div id="NCBIFooter_dynamic">
    <a id="help-desk-link" class="help_desk" href="" target="_blank">Support Center</a>
    <a id="help-desk-link" class="help_desk" href="https://support.ncbi.nlm.nih.gov/ics/support/KBList.asp?Time=2019-11-20T03:30:04-05:00&amp;Snapshot=%2Fprojects%2FPMC%2FPMCViewer@4.46&amp;Host=portal105&amp;ncbi_phid=CE8CF48CDD4EE29100000000067C0439&amp;ncbi_session=CE8C6010DD4F8B31_0740SID&amp;from=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC3676425%2F&amp;Db=pmc&amp;folderID=132&amp;Ncbi_App=pmc&amp;Page=literature&amp;style=classic&amp;deptID=28049" target="_blank">Support Center</a>
    
</div>

                            <div class="footer" id="footer">
    
    <div class="subfooter"> </div><script type="text/javascript" src="/portal/portal3rc.fcgi/static/js/preloaderWidget.js"> </script>
    <div id="external-disclaimer" class="offscreen_noflow">
        External link. Please review our <a href="https://www.nlm.nih.gov/privacy.html">privacy policy</a>.
    </div>    
    <div id="ncbifooter" class="contact_info">      
        <div id="footer-contents-right">
            <div id="nlm_thumb_logo">
                <a href="https://www.nlm.nih.gov" title="NLM">NLM</a>
            </div>
            <div id="nih_thumb_logo">
                <a href="https://www.nih.gov" title="NIH">NIH</a>
            </div>
            <div id="hhs_thumb_logo">
                <a href="https://www.hhs.gov" title="DHHS">DHHS</a>
            </div>
            <div id="usagov_thumb_logo">
                <a href="https://www.usa.gov" title="USA.gov">USA.gov</a>
            </div>         
        </div>
        
        <div id="footer-contents-left">
            <p class="address vcard">
                <span class="url">
                    <a class="fn url newdomain" href="https://www.ncbi.nlm.nih.gov">National Center for
                        Biotechnology Information</a>,
                </span> <span class="org url newdomain"><a href="https://www.nlm.nih.gov/">U.S. National Library of Medicine</a></span>
                <span class="adr">
                    <span class="street-address">8600 Rockville Pike</span>, <span class="locality">Bethesda</span>
                    <span class="region">MD</span>, <span class="postal-code">20894</span>
                    <span class="country-name">USA</span>
                </span>
            </p>
            
            <a href="/home/about/policies.shtml">Policies and Guidelines</a> | <a href="/home/about/contact.shtml">Contact</a>
        </div>
    </div>
    <script type="text/javascript" src="/portal/portal3rc.fcgi/rlib/js/InstrumentOmnitureBaseJS/InstrumentNCBIConfigJS/InstrumentNCBIBaseJS/InstrumentPageStarterJS.js?v=1"> </script>    
    <script type="text/javascript" src="/portal/portal3rc.fcgi/static/js/hfjs2.js"> </script>
</div>
                        </div>
                    </div>
                    <!--/.page-->
                </div>
                <!--/.wrap-->
            </div><!-- /.twelve_col -->
        <div class="ui-ncbiautocomplete-holder shadow ui-ncbiautocomplete-holder-clearfix" aria-live="assertive" style="display: none; top: 68.1px; left: 377.2px; width: 670px; z-index: 1001;"><ul class="ui-ncbiautocomplete-options" role="listbox" aria-activedescendant="term"></ul><div class="ui-ncbiautocomplete-actions shadow" style="display: block;"><a class="ui-ncbiautocomplete-link-pref" style="display: none;">Preferences</a><a href="#" class="ui-ncbiautocomplete-link-off ui-ncbiautocomplete-link-pref-right" style="display: block;">Turn off</a></div></div><div style="display: none; top: -100px; left: -100px;" aria-live="assertive" aria-hidden="true" class="ui-helper-reset ui-ncbipopper-wrapper ui-ncbipopper-basic">External link. Please review our <a href="https://www.nlm.nih.gov/privacy.html">privacy policy</a>.</div></div>
        <!-- /.grid -->

        <span class="PAFAppResources"></span>
        
        <!-- BESelector tab -->
        
        
        
        <noscript><img alt="statistics" src="/stat?jsdisabled=true&amp;ncbi_db=pmc&amp;ncbi_pdid=article&amp;ncbi_acc=&amp;ncbi_domain=nihpa&amp;ncbi_report=record&amp;ncbi_type=fulltext&amp;ncbi_objectid=&amp;ncbi_pcid=/articles/PMC3676425/&amp;ncbi_app=pmc" /></noscript>
        
        
        <!-- usually for JS scripts at page bottom -->
        <!--<component id="PageFixtures" label="styles"></component>-->
    

<!-- CE8C6010DD4F8B31_0740SID /projects/PMC/PMCViewer@4.46 portal105 v4.1.r585844 Mon, May 06 2019 02:53:16 -->

<script type="text/javascript" src="//static.pubmed.gov/portal/portal3rc.fcgi/4160049/js/3879255/4121861/3818874/4168176/3821238/4117325/4087685/4072593/4076480/3921943/4105668/4065628.js" snapshot="pmc"></script>
<div class="ui-dialog ui-widget ui-widget-content ui-corner-all ui-front" style="display: none;" tabindex="-1" role="dialog" aria-describedby="epubDialog" aria-labelledby="ui-id-1"><div class="ui-dialog-titlebar ui-widget-header ui-corner-all ui-helper-clearfix"><span id="ui-id-1" class="ui-dialog-title">Making articles easier to read in PMC</span><button type="button" class="ui-button ui-widget ui-state-default ui-corner-all ui-button-icon-only ui-dialog-titlebar-close" role="button" title="Close"><span class="ui-button-icon-primary ui-icon ui-icon-closethick"></span><span class="ui-button-text">Close</span></button></div><div id="epubDialog" style="display: block;" class="ui-dialog-content ui-widget-content">  <p>We are experimenting with display styles that make it easier to read articles     in PMC.     Our first effort uses eBook readers, which have several "ease of reading"     features already built in.</p>  <p>These PMC articles are best viewed in the <em>iBooks     reader</em>. You may notice problems with the display of certain parts of an article     in other eReaders.</p>  <div class="ui-dialog-buttonpane ui-widget-content ui-helper-clearfix"><button id="cancelEpub" class="ui-state-default ui-corner-all">Cancel</button><button id="downloadEpub" style="float: left" class="ui-state-default ui-corner-all">Download article</button></div>          </div></div></body></html>